The	O
Ets	O
protein	O
Spi-B	B-protein
is	O
expressed	O
exclusively	O
in	O
B	B-cell_type
cells	I-cell_type
and	O
T	B-cell_type
cells	I-cell_type
during	O
development	O
.	O

Spi-B	B-protein
and	O
PU.1	B-protein
are	O
hematopoietic-specific	B-protein
transcription	I-protein
factors	I-protein
that	O
constitute	O
a	O
subfamily	O
of	O
the	O
Ets	B-protein
family	I-protein
of	O
DNA-binding	B-protein
proteins	I-protein
.	O

Here	O
we	O
show	O
that	O
contrary	O
to	O
previous	O
reports	O
,	O
PU.1	B-protein
and	O
Spi-B	B-protein
have	O
very	O
different	O
expression	O
patterns	O
.	O

PU.1	B-protein
is	O
expressed	O
at	O
high	O
levels	O
in	O
B	B-cell_type
cells	I-cell_type
,	O
mast	B-cell_type
cells	I-cell_type
,	O
megakaryocytes	B-cell_type
,	O
macrophages	B-cell_type
,	O
neutrophils	B-cell_type
,	O
and	O
immature	B-cell_type
erythroid	I-cell_type
cells	I-cell_type
and	O
at	O
lower	O
levels	O
in	O
mature	B-cell_type
erythrocytes	I-cell_type
.	O

PU.1	B-protein
is	O
completely	O
absent	O
from	O
peripheral	B-cell_type
T	I-cell_type
cells	I-cell_type
and	O
most	O
T	B-cell_line
cell	I-cell_line
lines	I-cell_line
based	O
on	O
sensitive	O
RT-PCR	O
assays	O
.	O

In	O
contrast	O
,	O
Spi-B	B-protein
is	O
expressed	O
exclusively	O
in	O
lymphoid	B-cell_type
cells	I-cell_type
and	O
can	O
be	O
detected	O
in	O
early	O
fetal	O
thymus	O
and	O
spleen	O
.	O

In	O
situ	O
hybridizations	O
of	O
adult	O
murine	O
tissues	O
demonstrate	O
Spi-B	B-RNA
mRNA	I-RNA
in	O
the	O
medulla	O
of	O
the	O
thymus	O
,	O
the	O
white	O
pulp	O
of	O
the	O
spleen	O
,	O
and	O
the	O
germinal	O
centers	O
of	O
lymph	O
nodes	O
.	O

Spi-B	B-protein
expression	O
is	O
very	O
abundant	O
in	O
B	B-cell_type
cells	I-cell_type
and	O
both	O
Spi-B	B-RNA
mRNA	I-RNA
and	O
protein	O
are	O
detected	O
in	O
some	O
T	B-cell_type
cells	I-cell_type
.	O

In	O
situ	O
hybridization	O
and	O
Northern	O
blot	O
analysis	O
suggest	O
that	O
Spi-B	B-protein
gene	O
expression	O
increases	O
during	O
B	O
cell	O
maturation	O
and	O
decreases	O
during	O
T	O
cell	O
maturation	O
.	O

Gel-retardation	O
experiments	O
show	O
that	O
Spi-B	B-protein
can	O
bind	O
to	O
all	O
putative	B-DNA
PU.1	I-DNA
binding	I-DNA
sites	I-DNA
,	O
but	O
do	O
not	O
reveal	O
any	O
preferred	O
Spi-B	B-DNA
binding	I-DNA
site	I-DNA
.	O

Finally	O
,	O
both	O
PU.1	B-protein
and	O
Spi-B	B-protein
function	O
as	O
transcriptional	O
activators	O
of	O
the	O
immunoglobulin	B-DNA
light-chain	I-DNA
enhancer	I-DNA
E	I-DNA
lambda	I-DNA
2.4	I-DNA
when	O
coexpressed	O
with	O
Pip	B-protein
(	O
PU.1-interaction	B-protein
partner	I-protein
)	O
in	O
NIH-3T3	B-cell_line
cells	I-cell_line
.	O

Taken	O
together	O
,	O
these	O
data	O
suggest	O
that	O
differences	O
in	O
patterns	O
of	O
expression	O
between	O
Spi-B	B-protein
and	O
PU.1	B-protein
distinguish	O
the	O
function	O
of	O
each	O
protein	O
during	O
development	O
of	O
the	O
immune	O
system	O
.	O

The	NULL
Ets	NULL
Protein	NULL
Spi-B	NULL
Is	NULL
Expressed	NULL
Exclusively	NULL
in	NULL
B	NULL
Cells	NULL
and	NULL
T	NULL
Cells	NULL
during	NULL
Development	NULL
By	NULL
Gloria	NULL
H.	NULL
Su	NULL
,	NULL
*	NULL
Hon	NULL
S.	NULL
Ip	NULL
,	NULL
*	NULL
Bradley	NULL
S.	NULL
Cobb	NULL
,	NULL
*	NULL
Min-Min	NULL
Lu	NULL
,	NULL
t	NULL
Hui-Min	NULL
Chen	NULL
,	NULL
!	NULL

and	NULL
M.	NULL
Celeste	NULL
Simon**t	NULL
From	NULL
the	NULL
*Committee	NULL
on	NULL
Immunology	NULL
,	NULL
*Department	NULL
of	NULL
Medicine	NULL
,	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
University	NULL
of	NULL
Chicago	NULL
,	NULL
Chicago	NULL
,	NULL
Illinois	NULL
60637	NULL
;	NULL
and	NULL
the	NULL
Hematology	NULL
/Oncology	NULL
Division	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Beth	NULL
Israel	NULL
Hospital	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
Summary	NULL
Spi-B	NULL
and	NULL
PU.1	NULL
are	NULL
hematopoietic-specific	NULL
transcription	NULL
factors	NULL
that	NULL
constitute	NULL
a	NULL
subfamily	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
contrary	NULL
to	NULL
previous	NULL
reports	NULL
,	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
have	NULL
very	NULL
different	NULL
expression	NULL
patterns	NULL
.	NULL

PU.1	NULL
is	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
mast	NULL
cells	NULL
,	NULL
megakaryocytes	NULL
,	NULL
macrophages	NULL
,	NULL
neutrophils	NULL
,	NULL
and	NULL
immature	NULL
erythroid	NULL
cells	NULL
and	NULL
at	NULL
lower	NULL
levels	NULL
in	NULL
mature	NULL
erythrocytes	NULL
.	NULL

PU.1	NULL
is	NULL
completely	NULL
absent	NULL
from	NULL
peripheral	NULL
T	NULL
cells	NULL
and	NULL
most	NULL
T	NULL
cell	NULL
lines	NULL
based	NULL
on	NULL
sensitive	NULL
RT-PCR	NULL
assays	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Spi-B	NULL
is	NULL
expressed	NULL
exclusively	NULL
in	NULL
lymphoid	NULL
cells	NULL
and	NULL
can	NULL
be	NULL
detected	NULL
in	NULL
early	NULL
fetal	NULL
thymus	NULL
and	NULL
spleen	NULL
.	NULL

In	NULL
situ	NULL
hybridizations	NULL
of	NULL
adult	NULL
murine	NULL
tissues	NULL
demonstrate	NULL
Spi-B	NULL
mRNA	NULL
in	NULL
the	NULL
medulla	NULL
of	NULL
the	NULL
thymus	NULL
,	NULL
the	NULL
white	NULL
pulp	NULL
of	NULL
the	NULL
spleen	NULL
,	NULL
and	NULL
the	NULL
germinal	NULL
centers	NULL
of	NULL
lymph	NULL
nodes	NULL
.	NULL

Spi-B	NULL
expression	NULL
is	NULL
very	NULL
abundant	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
both	NULL
Spi-B	NULL
mRNA	NULL
and	NULL
protein	NULL
are	NULL
detected	NULL
in	NULL
some	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
situ	NULL
hybridization	NULL
and	NULL
Northern	NULL
blot	NULL
analysis	NULL
suggest	NULL
that	NULL
Spi-B	NULL
gene	NULL
expression	NULL
increases	NULL
during	NULL
B	NULL
cell	NULL
maturation	NULL
and	NULL
decreases	NULL
during	NULL
T	NULL
cell	NULL
maturation	NULL
.	NULL

Gel-retardation	NULL
experiments	NULL
show	NULL
that	NULL
Spi-B	NULL
can	NULL
bind	NULL
to	NULL
all	NULL
putative	NULL
PU.1	NULL
binding	NULL
sites	NULL
,	NULL
but	NULL
do	NULL
not	NULL
reveal	NULL
any	NULL
preferred	NULL
Spi-B	NULL
binding	NULL
site	NULL
.	NULL

Finally	NULL
,	NULL
both	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
function	NULL
as	NULL
transcriptional	NULL
activators	NULL
of	NULL
the	NULL
immunoglobulin	NULL
light-chain	NULL
enhancer	NULL
Ey	NULL
,	NULL
when	NULL
coexpressed	NULL
with	NULL
Pip	NULL
(	NULL
PU.l-interaction	NULL
partner	NULL
)	NULL
in	NULL
NIH-3T3	NULL
cells	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
differences	NULL
in	NULL
patterns	NULL
of	NULL
expression	NULL
between	NULL
Spi-B	NULL
and	NULL
PU.1	NULL
distinguish	NULL
the	NULL
function	NULL
of	NULL
each	NULL
protein	NULL
during	NULL
development	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Hematopoiesis	NULL
generates	NULL
eight	NULL
distinct	NULL
lineages	NULL
from	NULL
self-renewing	NULL
pluripotential	NULL
stem	NULL
cells	NULL
,	NULL
which	NULL
then	NULL
differentiate	NULL
into	NULL
mature	NULL
blood	NULL
cells	NULL
.	NULL

The	NULL
molecular	NULL
mechanisms	NULL
underlying	NULL
self-renewal	NULL
and	NULL
lineage	NULL
commitment	NULL
of	NULL
stem	NULL
cells	NULL
have	NULL
not	NULL
been	NULL
resolved	NULL
.	NULL

However	NULL
,	NULL
the	NULL
process	NULL
is	NULL
regulated	NULL
in	NULL
part	NULL
by	NULL
hematopoietic-specific	NULL
transcription	NULL
factors	NULL
.	NULL

For	NULL
example	NULL
,	NULL
stem	NULL
cell	NULL
leukemia	NULL
(	NULL
SCL	NULL
)	NULL
!	NULL

is	NULL
required	NULL
for	NULL
yolk	NULL
sac	NULL
hematopoiesis	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
,	NULL
GATA-1	NULL
regulates	NULL
red	NULL
cell	NULL
maturation	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
;	NULL
Ikaros	NULL
is	NULL
important	NULL
for	NULL
the	NULL
development	NULL
of	NULL
lymphocytes	NULL
,	NULL
natural	NULL
killer	NULL
cells	NULL
,	NULL
and	NULL
neutrophils	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
;	NULL
and	NULL
Oct-2	NULL
is	NULL
essential	NULL
for	NULL
T	NULL
cell-independent	NULL
B	NULL
cell	NULL
activation	NULL
and	NULL
B	NULL
cell	NULL
maturation	NULL
into	NULL
immunoglobulin	NULL
secreting	NULL
cells	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

The	NULL
function	NULL
of	NULL
a	NULL
transcription	NULL
factor	NULL
in	NULL
hematopoiesis	NULL
is	NULL
somewhat	NULL
correlated	NULL
to	NULL
its	NULL
expression	NULL
pat-tern	NULL
.	NULL

PU.1	NULL
is	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
granulo-cytes	NULL
,	NULL
monocytes	NULL
,	NULL
and	NULL
immature	NULL
erythroid	NULL
cells	NULL
(	NULL
9	NULL
,	NULL
10	NULL
,	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
determined	NULL
that	NULL
PU.1~'~-defi-	NULL
'	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
CAT	NULL
,	NULL
chloramphenical	NULL
acetyl	NULL
transferase	NULL
;	NULL
DN	NULL
,	NULL
double	NULL
negative	NULL
;	NULL
DP	NULL
,	NULL
double	NULL
positive	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
;	NULL
FcyR	NULL
,	NULL
Fo	NULL
fragments	NULL
;	NULL
IVT	NULL
,	NULL
in	NULL
vitro-translated	NULL
;	NULL
RT	NULL
,	NULL
reverse	NULL
transcribed	NULL
;	NULL
SCL	NULL
,	NULL
stem	NULL
cell	NULL
leukemia	NULL
;	NULL
SP	NULL
,	NULL
single	NULL
positive	NULL
.	NULL

cient	NULL
embryos	NULL
die	NULL
between	NULL
days	NULL
16	NULL
and	NULL
18	NULL
of	NULL
gestation	NULL
and	NULL
mutant	NULL
embryos	NULL
do	NULL
not	NULL
produce	NULL
T	NULL
and	NULL
B	NULL
lymphocytes	NULL
,	NULL
gran-ulocytes	NULL
,	NULL
and	NULL
monocytes	NULL
(	NULL
13	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
some	NULL
day	NULL
16.5	NULL
embryos	NULL
are	NULL
also	NULL
anemic	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Transcription	NULL
factors	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
are	NULL
widely	NULL
studied	NULL
as	NULL
key	NULL
regulators	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
the	NULL
immune	NULL
response	NULL
and	NULL
cellular	NULL
proliferation	NULL
.	NULL

Spi-B	NULL
and	NULL
PU.1	NULL
are	NULL
members	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
,	NULL
which	NULL
now	NULL
includes	NULL
~20	NULL
members	NULL
.	NULL

Spi-B	NULL
was	NULL
cloned	NULL
from	NULL
a	NULL
Burkitt	NULL
lymphoma	NULL
cDNA	NULL
library	NULL
using	NULL
the	NULL
human	NULL
PU.1	NULL
Ets	NULL
DNA-binding	NULL
domain	NULL
as	NULL
a	NULL
probe	NULL
(	NULL
12	NULL
)	NULL
,	NULL
and	NULL
it	NULL
shares	NULL
a	NULL
67	NULL
%	NULL
amino	NULL
acid	NULL
Ets-domain	NULL
identity	NULL
and	NULL
43	NULL
%	NULL
overall	NULL
amino	NULL
acid	NULL
sequence	NULL
identity	NULL
to	NULL
PU.1	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Like	NULL
most	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
members	NULL
,	NULL
Spi-B	NULL
has	NULL
the	NULL
DNA-binding	NULL
domain	NULL
at	NULL
its	NULL
basic	NULL
carboxy	NULL
terminus	NULL
and	NULL
an	NULL
acidic	NULL
amino-terminal	NULL
domain	NULL
that	NULL
corresponds	NULL
to	NULL
the	NULL
transactiva-tional	NULL
domain	NULL
in	NULL
PU.1	NULL
.	NULL

PU.1	NULL
and	NULL
Spi-B	NULL
are	NULL
the	NULL
most	NULL
distantly	NULL
related	NULL
genes	NULL
to	NULL
other	NULL
Ets	NULL
family	NULL
members	NULL
,	NULL
as	NULL
their	NULL
Ets	NULL
domains	NULL
present	NULL
only	NULL
40	NULL
%	NULL
identity	NULL
to	NULL
Ets-1	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Spi-B	NULL
can	NULL
bind	NULL
specifically	NULL
to	NULL
the	NULL
putative	NULL
PU.1	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
SV40	NULL
promoter	NULL
,	NULL
and	NULL
can	NULL
also	NULL
transactivate	NULL
a	NULL
reporter	NULL
construct	NULL
containing	NULL
multiple	NULL
PU	NULL
boxes	NULL
.	NULL

Ray	NULL
et	NULL
al	NULL
.	NULL

reported	NULL
that	NULL
Spi-B	NULL
has	NULL
an	NULL
identical	NULL
pattern	NULL
of	NULL
expression	NULL
to	NULL
203	NULL
__	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

©	NULL
The	NULL
Rockefeller	NULL
University	NULL
Press	NULL
«	NULL
0022-1007/96/07/203/12	NULL
$	NULL
2.00	NULL
Volume	NULL
184	NULL
July	NULL
1996	NULL
203-214	NULL
PU.1	NULL
and	NULL
is	NULL
expressed	NULL
in	NULL
all	NULL
hematopoietic	NULL
lineages	NULL
except	NULL
T	NULL
cells	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
report	NULL
that	NULL
significant	NULL
amounts	NULL
of	NULL
Spi-B	NULL
mRNA	NULL
are	NULL
detected	NULL
in	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

On	NULL
the	NULL
contrary	NULL
,	NULL
PU.1	NULL
mRNA	NULL
can	NULL
not	NULL
be	NULL
detected	NULL
by	NULL
the	NULL
most	NULL
sensitive	NULL
means	NULL
,	NULL
such	NULL
as	NULL
RT-PCR	NULL
,	NULL
in	NULL
purified	NULL
human	NULL
peripheral	NULL
T	NULL
cells	NULL
or	NULL
any	NULL
T	NULL
cell	NULL
lines	NULL
examined	NULL
.	NULL

Spi-B	NULL
is	NULL
not	NULL
present	NULL
in	NULL
any	NULL
other	NULL
non-lymphoid	NULL
cells	NULL
based	NULL
on	NULL
in	NULL
situ	NULL
hybridization	NULL
analyses	NULL
.	NULL

Spi-B	NULL
is	NULL
first	NULL
expressed	NULL
in	NULL
the	NULL
fetal	NULL
thymus	NULL
and	NULL
spleen	NULL
,	NULL
and	NULL
Spi-B	NULL
mRNA	NULL
is	NULL
localized	NULL
to	NULL
the	NULL
medulla	NULL
of	NULL
the	NULL
thymus	NULL
,	NULL
white	NULL
pulp	NULL
of	NULL
the	NULL
spleen	NULL
,	NULL
and	NULL
the	NULL
germinal	NULL
centers	NULL
of	NULL
the	NULL
lymph	NULL
nodes	NULL
of	NULL
adult	NULL
mice	NULL
.	NULL

Spi-B	NULL
is	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
all	NULL
predicted	NULL
PU.1-binding	NULL
sites	NULL
in	NULL
vitro	NULL
,	NULL
including	NULL
myeloid	NULL
target	NULL
genes	NULL
.	NULL

Both	NULL
Spi-B	NULL
and	NULL
PU.1	NULL
in	NULL
Clone	NULL
13	NULL
B	NULL
cells	NULL
bind	NULL
to	NULL
the	NULL
functional	NULL
PU.1-binding	NULL
site	NULL
in	NULL
the	NULL
Igk	NULL
3	NULL
'	NULL
enhancer	NULL
.	NULL

Both	NULL
Pu.1	NULL
and	NULL
Spi-B	NULL
function	NULL
as	NULL
transcriptional	NULL
activators	NULL
of	NULL
the	NULL
IgA	NULL
2-4	NULL
enhancer	NULL
.	NULL

We	NULL
postulate	NULL
that	NULL
Spi-B	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
lymphocytic	NULL
development	NULL
based	NULL
on	NULL
its	NULL
pattern	NULL
of	NULL
expression	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Northern	NULL
Analysis	NULL
and	NULL
RT-PCR	NULL
.	NULL

-	NULL
Total	NULL
RNAs	NULL
were	NULL
prepared	NULL
from	NULL
cells	NULL
or	NULL
tissues	NULL
using	NULL
Trizol	NULL
(	NULL
GIBCO	NULL
BRL	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Poly-A*	NULL
RNAs	NULL
were	NULL
then	NULL
prepared	NULL
from	NULL
total	NULL
cellular	NULL
RNAs	NULL
using	NULL
the	NULL
Oligotex	NULL
poly-A*	NULL
mRNA	NULL
purification	NULL
protocol	NULL
(	NULL
QIAGEN	NULL
,	NULL
Chatsworth	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Poly-A*	NULL
RNA	NULL
samples	NULL
(	NULL
2	NULL
ug	NULL
each	NULL
)	NULL
were	NULL
separated	NULL
by	NULL
elec-trophoresis	NULL
on	NULL
1.2	NULL
%	NULL
agarose	NULL
gels	NULL
containing	NULL
formaldehyde	NULL
and	NULL
blotted	NULL
onto	NULL
Hybond-N+	NULL
membranes	NULL
.	NULL

Hybridizations	NULL
were	NULL
carried	NULL
out	NULL
at	NULL
42°C	NULL
in	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
50	NULL
mM	NULL
hepes	NULL
(	NULL
pH	NULL
7.0	NULL
)	NULL
,	NULL
5	NULL
%	NULL
Denhardt	NULL
's	NULL
solution	NULL
,	NULL
3X	NULL
SSC	NULL
,	NULL
0.16	NULL
mg/ml	NULL
salmon	NULL
sperm	NULL
DNA	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
,	NULL
and	NULL
5	NULL
%	NULL
dextran	NULL
sulfite	NULL
.	NULL

Membranes	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
2X	NULL
SSC/0.1	NULL
%	NULL
SDS	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
10	NULL
min	NULL
,	NULL
and	NULL
twice	NULL
in	NULL
0.1X	NULL
SSC/0.1	NULL
%	NULL
SDS	NULL
at	NULL
55°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
human	NULL
Spi-B	NULL
probe	NULL
(	NULL
3'-UTR	NULL
,	NULL
from	NULL
the	NULL
EcoRV	NULL
site	NULL
in	NULL
Spi-B	NULL
to	NULL
the	NULL
EcoRI	NULL
site	NULL
in	NULL
pBluescript	NULL
,	NULL
~300	NULL
bp	NULL
long	NULL
)	NULL
and	NULL
murine	NULL
Spi-B	NULL
probe	NULL
(	NULL
3'-UTR	NULL
,	NULL
NdeI	NULL
to	NULL
BamHI	NULL
,	NULL
600	NULL
bp	NULL
long	NULL
)	NULL
were	NULL
labeled	NULL
by	NULL
random	NULL
hexapriming	NULL
.	NULL

For	NULL
RT-PCR	NULL
analysis	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
reverse	NULL
transcribed	NULL
(	NULL
RT	NULL
)	NULL
in	NULL
a	NULL
20-wl	NULL
volume	NULL
with	NULL
reagents	NULL
from	NULL
Perkin-Elmer	NULL
(	NULL
Nor-walk	NULL
,	NULL
CT	NULL
)	NULL
:	NULL
Moloney	NULL
murine	NULL
Leukemia	NULL
virus	NULL
reverse	NULL
transcriptase	NULL
(	NULL
50	NULL
U	NULL
)	NULL
,	NULL
RNase	NULL
inhibitor	NULL
(	NULL
20	NULL
U	NULL
)	NULL
,	NULL
dNTPs	NULL
(	NULL
1	NULL
mM	NULL
final	NULL
concentration	NULL
)	NULL
,	NULL
Oligo	NULL
d	NULL
(	NULL
t	NULL
)	NULL
;	NULL
,	NULL
(	NULL
2.5	NULL
mM	NULL
final	NULL
concentration	NULL
)	NULL
,	NULL
MgCl	NULL
,	NULL
(	NULL
5	NULL
mM	NULL
final	NULL
concentration	NULL
)	NULL
,	NULL
KCI	NULL
(	NULL
50	NULL
mM	NULL
final	NULL
concentration	NULL
)	NULL
,	NULL
and	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.3	NULL
(	NULL
10	NULL
mM	NULL
final	NULL
concentration	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
incubated	NULL
at	NULL
42°C	NULL
for	NULL
15	NULL
min	NULL
99°C	NULL
for	NULL
5	NULL
min	NULL
,	NULL
and	NULL
5°C	NULL
for	NULL
5	NULL
min	NULL
.	NULL

The	NULL
salt	NULL
concentration	NULL
for	NULL
PCR	NULL
was	NULL
optimized	NULL
using	NULL
the	NULL
Optiprime	NULL
kit	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
each	NULL
set	NULL
of	NULL
primers	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instruction	NULL
.	NULL

The	NULL
entire	NULL
RT	NULL
reaction	NULL
was	NULL
subjected	NULL
to	NULL
30	NULL
cycles	NULL
of	NULL
denaturation	NULL
at	NULL
94°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
primer	NULL
annealing	NULL
at	NULL
65°C	NULL
,	NULL
and	NULL
primer	NULL
extension	NULL
at	NULL
72°C	NULL
for	NULL
2	NULL
min	NULL
.	NULL

Antibodies	NULL
.	NULL

-	NULL
The	NULL
coding	NULL
sequence	NULL
of	NULL
human	NULL
Spi-B	NULL
cDNA	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
the	NULL
bacterial	NULL
expression	NULL
vector	NULL
pGEX-4T3	NULL
(	NULL
Pharmacia	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Spi-B-GST	NULL
fusion	NULL
protein	NULL
was	NULL
induced	NULL
at	NULL
1.25	NULL
mM	NULL
IPTG	NULL
and	NULL
subsequently	NULL
purified	NULL
using	NULL
the	NULL
Bulk	NULL
GST	NULL
Purification	NULL
Module	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

Polyclonal	NULL
anti-Spi-B	NULL
antisera	NULL
were	NULL
obtained	NULL
from	NULL
rabbits	NULL
immunized	NULL
with	NULL
the	NULL
Spi-B-GST	NULL
fusion	NULL
protein	NULL
(	NULL
Pocono	NULL
Rabbit	NULL
Farm	NULL
&	NULL
Labora-tory	NULL
,	NULL
Canadensis	NULL
,	NULL
PA	NULL
)	NULL
.	NULL

Monoclonal	NULL
anti-PU.1	NULL
antibody	NULL
was	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Inc	NULL
.	NULL

In	NULL
Vitro	NULL
Translation	NULL
and	NULL
Western	NULL
Blot	NULL
Analysis	NULL
.	NULL

-	NULL
IVT	NULL
proteins	NULL
were	NULL
synthesized	NULL
from	NULL
human	NULL
Spi-B	NULL
and	NULL
murine	NULL
PU.1	NULL
cDNA	NULL
linked	NULL
to	NULL
the	NULL
T7	NULL
promoter	NULL
in	NULL
pCDNA3	NULL
vectors	NULL
using	NULL
Promega	NULL
TNT	NULL
T7	NULL
Coupled	NULL
Reticulocyte	NULL
Lysate	NULL
System	NULL
.	NULL

IVT	NULL
proteins	NULL
were	NULL
quanti-tated	NULL
by	NULL
their	NULL
[	NULL
*	NULL
``	NULL
S	NULL
)	NULL
Jmethionine	NULL
incorporation	NULL
,	NULL
to	NULL
determine	NULL
that	NULL
equal	NULL
amounts	NULL
of	NULL
Spi-B	NULL
and	NULL
PU.1	NULL
proteins	NULL
were	NULL
loaded	NULL
for	NULL
each	NULL
assay	NULL
.	NULL

IVT	NULL
proteins	NULL
and	NULL
total	NULL
cell	NULL
lysates	NULL
obtained	NULL
from	NULL
2	NULL
X	NULL
10°	NULL
cells	NULL
each	NULL
were	NULL
subjected	NULL
to	NULL
12	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
elec-trophoresis	NULL
followed	NULL
by	NULL
electrotransfer	NULL
onto	NULL
nitrocellulose	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
probed	NULL
with	NULL
the	NULL
polyclonal	NULL
antiserum	NULL
to	NULL
Spi-B	NULL
in	NULL
10	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
and	NULL
5	NULL
%	NULL
nonfat	NULL
milk	NULL
.	NULL

The	NULL
immune	NULL
complexes	NULL
were	NULL
revealed	NULL
by	NULL
the	NULL
ECL	NULL
Western	NULL
blotting	NULL
detection	NULL
system	NULL
(	NULL
Amersham	NULL
Corp.	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Cell	NULL
Purification	NULL
.	NULL

_	NULL
To	NULL
purify	NULL
splenic	NULL
B	NULL
cells	NULL
,	NULL
ammonium	NULL
chloride-lysed	NULL
spleen	NULL
cells	NULL
were	NULL
subjected	NULL
to	NULL
anti-Thy1.2/complement	NULL
de-pletion	NULL
.	NULL

Splenic	NULL
T	NULL
cells	NULL
were	NULL
purified	NULL
from	NULL
red	NULL
cell-depleted	NULL
spleens	NULL
using	NULL
a	NULL
Mouse	NULL
T	NULL
Cell	NULL
Enrichment	NULL
Column	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Sys-tems	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
and	NULL
anti-J11D/complement	NULL
lysis	NULL
.	NULL

The	NULL
purity	NULL
of	NULL
final	NULL
cell	NULL
populations	NULL
was	NULL
determined	NULL
by	NULL
flow	NULL
cytometry	NULL
using	NULL
B220	NULL
(	NULL
B	NULL
cell	NULL
)	NULL
and	NULL
CD3	NULL
(	NULL
T	NULL
cell	NULL
)	NULL
surface	NULL
antigens	NULL
.	NULL

Purified	NULL
B	NULL
cells	NULL
were	NULL
determined	NULL
to	NULL
be	NULL
98	NULL
%	NULL
pure	NULL
,	NULL
and	NULL
T	NULL
cells	NULL
were	NULL
85	NULL
%	NULL
pure	NULL
.	NULL

For	NULL
T	NULL
cell	NULL
sorting	NULL
,	NULL
adult	NULL
BL/6	NULL
thymi	NULL
were	NULL
processed	NULL
into	NULL
single	NULL
cell	NULL
suspensions	NULL
and	NULL
resuspended	NULL
at	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
in	NULL
5	NULL
%	NULL
complete	NULL
media	NULL
(	NULL
5	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
1X	NULL
non-essential	NULL
amino	NULL
acids	NULL
,	NULL
1X	NULL
L-glutamine	NULL
,	NULL
1X	NULL
Pen-Strep	NULL
,	NULL
50	NULL
M	NULL
B-mercap-toethanol	NULL
in	NULL
DMEM	NULL
)	NULL
.	NULL

Thymocytes	NULL
were	NULL
incubated	NULL
with	NULL
anti-CD4	NULL
and	NULL
anti-CD8	NULL
antibodies	NULL
(	NULL
PharMingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
at	NULL
1	NULL
g/10°	NULL
cells	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
incubation	NULL
was	NULL
followed	NULL
by	NULL
two	NULL
washes	NULL
with	NULL
complete	NULL
media	NULL
.	NULL

Cells	NULL
were	NULL
resuspended	NULL
at	NULL
4	NULL
X	NULL
10°	NULL
cells/ml	NULL
in	NULL
complete	NULL
media	NULL
for	NULL
sorting	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

In	NULL
Situ	NULL
Hybridization	NULL
.	NULL

-	NULL
Adult	NULL
murine	NULL
tissues	NULL
(	NULL
thymus	NULL
,	NULL
lymph	NULL
nodes	NULL
,	NULL
heart	NULL
,	NULL
lung	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
liver	NULL
)	NULL
were	NULL
sectioned	NULL
and	NULL
mounted	NULL
for	NULL
in	NULL
situ	NULL
hybridization	NULL
.	NULL

Sense	NULL
and	NULL
anti-sense	NULL
riboprobes	NULL
were	NULL
made	NULL
from	NULL
the	NULL
3'-UTR	NULL
of	NULL
murine	NULL
Spi-B	NULL
(	NULL
NdeI	NULL
to	NULL
BamHI	NULL
)	NULL
linked	NULL
to	NULL
the	NULL
T7	NULL
promoter	NULL
in	NULL
pBluescript	NULL
.	NULL

The	NULL
protocol	NULL
utilized	NULL
was	NULL
essentially	NULL
as	NULL
described	NULL
by	NULL
Eichele	NULL
and	NULL
coworkers	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Tissues	NULL
were	NULL
fixed	NULL
in	NULL
4	NULL
%	NULL
paraformaldehyde/PBS	NULL
and	NULL
embedded	NULL
in	NULL
paraffin	NULL
.	NULL

The	NULL
sections	NULL
were	NULL
rehydrated	NULL
and	NULL
treated	NULL
with	NULL
20	NULL
mg/	NULL
mi	NULL
proteinase	NULL
K	NULL
,	NULL
and	NULL
0.1	NULL
M	NULL
pH	NULL
8	NULL
.	NULL

Pre-treated	NULL
slides	NULL
were	NULL
hybridized	NULL
overnight	NULL
at	NULL
60°C	NULL
.	NULL

The	NULL
hybridization	NULL
mix	NULL
contained	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
20	NULL
mM	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
8	NULL
,	NULL
0.3	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
EDTA	NULL
,	NULL
10	NULL
%	NULL
dextran	NULL
sulfate	NULL
,	NULL
0.02	NULL
%	NULL
BSA	NULL
,	NULL
0.5	NULL
mg/ml	NULL
tRNA	NULL
,	NULL
and	NULL
10	NULL
mM	NULL
DTT	NULL
.	NULL

S-labeled	NULL
riboprobe	NULL
was	NULL
mixed	NULL
with	NULL
the	NULL
hybridization	NULL
mix	NULL
at	NULL
140,000	NULL
cpm/l	NULL
(	NULL
90	NULL
ml/	NULL
slide	NULL
)	NULL
.	NULL

A	NULL
1/100th	NULL
volume	NULL
of	NULL
25	NULL
mM	NULL
5'-alpha-thio-ATP	NULL
was	NULL
added	NULL
to	NULL
the	NULL
probe	NULL
mix	NULL
,	NULL
followed	NULL
by	NULL
2	NULL
min	NULL
of	NULL
boiling	NULL
.	NULL

After	NULL
hybridization	NULL
,	NULL
slides	NULL
were	NULL
washed	NULL
with	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
2X	NULL
SSC	NULL
,	NULL
and	NULL
20	NULL
mM	NULL
DTT	NULL
for	NULL
60	NULL
min	NULL
at	NULL
65°C	NULL
(	NULL
high	NULL
stringency	NULL
wash	NULL
)	NULL
.	NULL

Slide	NULL
were	NULL
then	NULL
washed	NULL
with	NULL
STE	NULL
(	NULL
4X	NULL
SSC	NULL
,	NULL
20	NULL
mM	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
for	NULL
10	NULL
min	NULL
twice	NULL
at	NULL
37°C	NULL
,	NULL
followed	NULL
by	NULL
RNase	NULL
A	NULL
treatment	NULL
(	NULL
10	NULL
mg/ml	NULL
in	NULL
STE	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

This	NULL
high	NULL
stringency	NULL
wash	NULL
was	NULL
repeated	NULL
and	NULL
then	NULL
the	NULL
slides	NULL
were	NULL
washed	NULL
in	NULL
2X	NULL
SSC	NULL
at	NULL
37°C	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assays	NULL
(	NULL
EMSAs	NULL
)	NULL
.	NULL

-	NULL
In	NULL
vitro-translated	NULL
(	NULL
IVT	NULL
)	NULL
proteins	NULL
(	NULL
1.3	NULL
jul	NULL
to	NULL
1.5	NULL
pl	NULL
)	NULL
or	NULL
nuclear	NULL
extracts	NULL
(	NULL
10	NULL
pg	NULL
)	NULL
were	NULL
preincubated	NULL
on	NULL
ice	NULL
with	NULL
1	NULL
pg	NULL
of	NULL
double-stranded	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
and	NULL
0.4	NULL
g	NULL
of	NULL
salmon	NULL
sperm	NULL
DNA	NULL
in	NULL
5	NULL
%	NULL
Ficoll	NULL
binding	NULL
buffer	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
19	NULL
wl	NULL
.	NULL

For	NULL
competition	NULL
experiments	NULL
,	NULL
cold	NULL
competitor	NULL
oligonucleotide	NULL
(	NULL
200-300	NULL
ng	NULL
per	NULL
reaction	NULL
)	NULL
and	NULL
pre-immune	NULL
or	NULL
antiserum	NULL
were	NULL
also	NULL
added	NULL
at	NULL
this	NULL
step	NULL
.	NULL

Radiolabeled	NULL
probes	NULL
were	NULL
diluted	NULL
to	NULL
30,000	NULL
cpm/ul	NULL
and	NULL
1	NULL
jl	NULL
was	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
for	NULL
a	NULL
10-min	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Oli-	NULL
204	NULL
Ets	NULL
Protein	NULL
Spi-B	NULL
Is	NULL
Expressed	NULL
Exclusively	NULL
in	NULL
B	NULL
Cells	NULL
and	NULL
T	NULL
Cells	NULL
gonucleotides	NULL
were	NULL
synthesized	NULL
according	NULL
to	NULL
the	NULL
published	NULL
putative	NULL
PU.1	NULL
binding	NULL
sites	NULL
:	NULL
c-fes	NULL
(	NULL
15	NULL
)	NULL
GATCAAACCGCGGGAGGAGGAAGCGCGGAATCAGGA	NULL
c-fes	NULL
mutant	NULL
(	NULL
15	NULL
)	NULL
GATCAAACCGCGGGAGCACCGGGCGCGGAATCAGGA	NULL
SV	NULL
40	NULL
(	NULL
12	NULL
)	NULL
GATCTCGGGCTCGAGTCTGAAAGAGGAACTTGGTTA	NULL
SV40	NULL
mutant	NULL
(	NULL
12	NULL
)	NULL
GATCTCGGGCTCGAGTCTTGAAAGACCAACTTGGTT	NULL
Igk-3	NULL
'	NULL
enhancer	NULL
(	NULL
16	NULL
)	NULL
GATCCCTTTGAGGAACTGAAAACAGAACCTAGATC	NULL
Ig	NULL
J	NULL
chain	NULL
(	NULL
17	NULL
)	NULL
CTAGATTTTAAGAAAGCAGAAGCAGCAT	NULL
M-CSF	NULL
receptor	NULL
(	NULL
18	NULL
)	NULL
TCGACCTAGCTAAAAGGGGAAGAAGAGGATCAGC	NULL
Fcy	NULL
receptor	NULL
(	NULL
19	NULL
)	NULL
CTAGGCAATTTCCCTTCCTCTTTTCTAA	NULL
B-globin	NULL
(	NULL
11	NULL
)	NULL
GATCACCTTCCTATCAGAAAAAAAGGGGAAGCGATTAT	NULL
Transient	NULL
Transfection	NULL
and	NULL
CAT	NULL
Assays	NULL
.	NULL

-	NULL
The	NULL
CAT	NULL
reporter	NULL
construct	NULL
(	NULL
B	NULL
,	NULL
TKCAT	NULL
)	NULL
containing	NULL
multiple	NULL
copies	NULL
of	NULL
the	NULL
PU.1/Pip	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
lambda	NULL
chain	NULL
enhancer	NULL
Ey4	NULL
,	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
20	NULL
)	NULL
.	NULL

To	NULL
create	NULL
Pip/CMV	NULL
the	NULL
Pip	NULL
cDNA	NULL
was	NULL
subcloned	NULL
as	NULL
a	NULL
HindlIII-Xbal	NULL
fragment	NULL
into	NULL
the	NULL
HindIII	NULL
and	NULL
Xbal	NULL
sites	NULL
in	NULL
the	NULL
polylinker	NULL
of	NULL
pRc/CMV	NULL
(	NULL
Invitrogen	NULL
)	NULL
,	NULL
which	NULL
places	NULL
the	NULL
cDNA	NULL
insert	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
CMV	NULL
promoter	NULL
(	NULL
21	NULL
)	NULL
.	NULL

NIH-3T3	NULL
cells	NULL
were	NULL
transfected	NULL
using	NULL
Lipofectin	NULL
(	NULL
GIBCO	NULL
BRL	NULL
)	NULL
and	NULL
a	NULL
total	NULL
of	NULL
25	NULL
jg	NULL
of	NULL
DNA	NULL
.	NULL

Transfection	NULL
involved	NULL
5	NULL
jg	NULL
of	NULL
reporter	NULL
construct	NULL
and	NULL
10	NULL
pg	NULL
of	NULL
the	NULL
expression	NULL
constructs	NULL
,	NULL
with	NULL
the	NULL
balance	NULL
made	NULL
up	NULL
with	NULL
empty	NULL
expression	NULL
vector	NULL
.	NULL

After	NULL
48	NULL
h	NULL
at	NULL
37°C	NULL
,	NULL
cell	NULL
lysates	NULL
were	NULL
prepared	NULL
and	NULL
CAT	NULL
assays	NULL
performed	NULL
using	NULL
30	NULL
pl	NULL
of	NULL
lysate	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
20	NULL
)	NULL
.	NULL

TLC	NULL
plates	NULL
were	NULL
analyzed	NULL
on	NULL
a	NULL
Molecular	NULL
Dynamics	NULL
PhosphorImager	NULL
;	NULL
the	NULL
results	NULL
shown	NULL
here	NULL
represent	NULL
an	NULL
average	NULL
of	NULL
at	NULL
least	NULL
four	NULL
independent	NULL
transfections	NULL
.	NULL

Results	NULL
Spi-B	NULL
mRNAs	NULL
Are	NULL
Present	NULL
Exclusively	NULL
in	NULL
Murine	NULL
Thymus	NULL
,	NULL
Spleen	NULL
,	NULL
and	NULL
Lymph	NULL
Nodes	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
tissue-speci-ficity	NULL
of	NULL
Spi-B	NULL
mRNA	NULL
expression	NULL
,	NULL
tissues	NULL
from	NULL
day	NULL
18.5	NULL
mouse	NULL
embryos	NULL
and	NULL
adult	NULL
mice	NULL
were	NULL
analyzed	NULL
on	NULL
poly-A	NULL
*	NULL
Northern	NULL
blots	NULL
.	NULL

To	NULL
distinguish	NULL
the	NULL
expression	NULL
of	NULL
Spi-B	NULL
mRNA	NULL
compared	NULL
to	NULL
PU.1	NULL
mRNA	NULL
,	NULL
a	NULL
3	NULL
'	NULL
untranslated	NULL
region	NULL
(	NULL
3	NULL
'	NULL
UTR	NULL
)	NULL
probe	NULL
for	NULL
the	NULL
mouse	NULL
Spi-B	NULL
cDNA	NULL
was	NULL
used	NULL
.	NULL

Spi-B	NULL
mRNA	NULL
has	NULL
been	NULL
previously	NULL
detected	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
12	NULL
)	NULL
,	NULL
so	NULL
splenocytes	NULL
were	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
,	NULL
high	NULL
levels	NULL
of	NULL
Spi-B	NULL
mRNA	NULL
were	NULL
detected	NULL
in	NULL
adult	NULL
splenocytes	NULL
(	NULL
see	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

The	NULL
predominant	NULL
mRNA	NULL
species	NULL
was	NULL
3.0	NULL
kb	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
1.4-kb	NULL
species	NULL
found	NULL
in	NULL
human	NULL
cells	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

However	NULL
,	NULL
a	NULL
faint	NULL
1.5-kb	NULL
species	NULL
was	NULL
detected	NULL
.	NULL

Surprisingly	NULL
,	NULL
Spi-B	NULL
mRNA	NULL
was	NULL
detected	NULL
at	NULL
low	NULL
levels	NULL
in	NULL
adult	NULL
thymocytes	NULL
as	NULL
well	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
A4	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Spi~B	NULL
mRNAs	NULL
were	NULL
completely	NULL
absent	NULL
in	NULL
all	NULL
fetal	NULL
tissues	NULL
examined	NULL
including	NULL
heart	NULL
,	NULL
kidney	NULL
,	NULL
brain	NULL
,	NULL
and	NULL
liver	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
,	NULL
lanes	NULL
3-6	NULL
)	NULL
.	NULL

Adult	NULL
murine	NULL
tissues	NULL
were	NULL
also	NULL
examined	NULL
for	NULL
Spi-B	NULL
expression	NULL
,	NULL
including	NULL
heart	NULL
,	NULL
liver	NULL
,	NULL
lungs	NULL
,	NULL
lymph	NULL
nodes	NULL
,	NULL
small	NULL
intestine	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
testes	NULL
.	NULL

Be	NULL
205	NULL
Su	NULL
et	NULL
al	NULL
.	NULL

A	NULL
Splenocytes	NULL
Thymocytes	NULL
Fetal	NULL
heart	NULL
Fetal	NULL
kidney	NULL
Fetal	NULL
brain	NULL
Fetal	NULL
liver	NULL
3.0	NULL
-	NULL
Spi-B	NULL
1.4	NULL
-	NULL
a	NULL
»	NULL
wo	NULL
CAPDH	NULL
©	NULL
B	NULL
g	NULL
&	NULL
0	NULL
z	NULL
©	NULL
a	NULL
o	NULL
$	NULL
556	NULL
G	NULL
p	NULL
g	NULL
§	NULL
5	NULL
§§	NULL
f	NULL
$	NULL
G	NULL
£	NULL
G3	NULL
1	NULL
I	NULL
a	NULL
a	NULL
&	NULL
3.0	NULL
-	NULL
we	NULL
-	NULL
Hi	NULL
Spi-B	NULL
1.4	NULL
-	NULL
Wom	NULL
wee	NULL
GAPDH	NULL
Figure	NULL
1	NULL
.	NULL

The	NULL
tissue	NULL
distribution	NULL
of	NULL
Spi-B	NULL
expression	NULL
.	NULL

(	NULL
4	NULL
)	NULL
The	NULL
top	NULL
panel	NULL
shows	NULL
a	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
mRNA	NULL
samples	NULL
isolated	NULL
from	NULL
fetal	NULL
murine	NULL
tissues	NULL
,	NULL
adult	NULL
splenocytes	NULL
,	NULL
and	NULL
adult	NULL
thymocytes	NULL
hybridized	NULL
to	NULL
a	NULL
radiolabeled	NULL
Spi-B	NULL
3	NULL
'	NULL
UTR	NULL
probe	NULL
(	NULL
16-h	NULL
exposure	NULL
)	NULL
.	NULL

The	NULL
Spi-B	NULL
probe	NULL
hybridized	NULL
primarily	NULL
to	NULL
a	NULL
3.0-kb	NULL
species	NULL
and	NULL
a	NULL
smaller	NULL
1.5-kb	NULL
species	NULL
present	NULL
in	NULL
purified	NULL
splenocytes	NULL
and	NULL
thymocytes	NULL
.	NULL

The	NULL
bottom	NULL
panel	NULL
shows	NULL
hybridization	NULL
to	NULL
the	NULL
1.4-kb	NULL
glyceraldehyde	NULL
3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
probe	NULL
used	NULL
as	NULL
a	NULL
control	NULL
for	NULL
the	NULL
amount	NULL
of	NULL
RNA	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
top	NULL
panel	NULL
shows	NULL
a	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
RNA	NULL
samples	NULL
obtained	NULL
from	NULL
the	NULL
indicated	NULL
adult	NULL
murine	NULL
tissues	NULL
(	NULL
20-h	NULL
exposure	NULL
)	NULL
.	NULL

A	NULL
3.0-kb	NULL
transcript	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
spleen	NULL
and	NULL
lymph	NULL
nodes	NULL
;	NULL
however	NULL
,	NULL
no	NULL
1.5-kb	NULL
species	NULL
was	NULL
apparent	NULL
in	NULL
this	NULL
experiment	NULL
.	NULL

GAPDH	NULL
hybridization	NULL
is	NULL
shown	NULL
in	NULL
the	NULL
bottom	NULL
panel	NULL
.	NULL

A	NULL
larger	NULL
GAPDH	NULL
transcript	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
testes	NULL
sample	NULL
.	NULL

sides	NULL
the	NULL
spleen	NULL
,	NULL
Spi-B	NULL
mRNAs	NULL
were	NULL
also	NULL
detected	NULL
in	NULL
axil-lary	NULL
and	NULL
mesenteric	NULL
lymph	NULL
nodes	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
6	NULL
)	NULL
.	NULL

No	NULL
other	NULL
organs	NULL
from	NULL
adult	NULL
mice	NULL
exhibited	NULL
significant	NULL
Spi-B	NULL
expression	NULL
.	NULL

To	NULL
further	NULL
localize	NULL
Spi-B	NULL
mRNA	NULL
expression	NULL
,	NULL
in	NULL
situ	NULL
hybridization	NULL
was	NULL
performed	NULL
on	NULL
adult	NULL
mouse	NULL
tissues	NULL
.	NULL

In	NULL
adult	NULL
tissues	NULL
,	NULL
Spi-B	NULL
mRNA	NULL
was	NULL
observed	NULL
exclusively	NULL
in	NULL
the	NULL
thymus	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
lymph	NULL
nodes	NULL
(	NULL
Figs	NULL
.	NULL

2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Only	NULL
background	NULL
signals	NULL
were	NULL
detected	NULL
in	NULL
heart	NULL
,	NULL
intestines	NULL
,	NULL
kidney	NULL
,	NULL
stomach	NULL
,	NULL
lung	NULL
,	NULL
and	NULL
liver	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
assess	NULL
positive	NULL
in	NULL
situ	NULL
hybridization	NULL
,	NULL
sense	NULL
and	NULL
antisense	NULL
3	NULL
'	NULL
UTR	NULL
Spi-B	NULL
probes	NULL
were	NULL
incubated	NULL
with	NULL
tissue	NULL
sections	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
a	NULL
,	NULL
d	NULL
,	NULL
and	NULL
g	NULL
,	NULL
the	NULL
sense	NULL
probe	NULL
gave	NULL
weak	NULL
hybridization	NULL
signals	NULL
as	NULL
compared	NULL
to	NULL
the	NULL
antisense	NULL
probe	NULL
(	NULL
b	NULL
,	NULL
e	NULL
,	NULL
and	NULL
h	NULL
)	NULL
.	NULL

He-matoxylin-	NULL
and	NULL
eosin-stained	NULL
sections	NULL
of	NULL
thymus	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
lymph	NULL
nodes	NULL
are	NULL
shown	NULL
for	NULL
comparison	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
c	NULL
,	NULL
f	NULL
,	NULL
and	NULL
i	NULL
)	NULL
.	NULL

In	NULL
the	NULL
thymus	NULL
,	NULL
Spi~B	NULL
gene	NULL
expression	NULL
was	NULL
restricted	NULL
to	NULL
the	NULL
medulla	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
b	NULL
)	NULL
.	NULL

As	NULL
T	NULL
cells	NULL
mature	NULL
,	NULL
thymocytes	NULL
Figure	NULL
2.	NULL
diolabeled	NULL
sense	NULL
3	NULL
'	NULL
UTR	NULL
Spi-B	NULL
riboprobe	NULL
(	NULL
a	NULL
,	NULL
d	NULL
,	NULL
and	NULL
g	NULL
)	NULL
and	NULL
an	NULL
antisense	NULL
Spi-B	NULL
riboprobe	NULL
(	NULL
b	NULL
,	NULL
e	NULL
,	NULL
and	NULL
A	NULL
)	NULL
.	NULL

Specific	NULL
hybridization	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
thymus	NULL
medulla	NULL
(	NULL
b	NULL
)	NULL
,	NULL
white	NULL
pulp	NULL
of	NULL
the	NULL
spleen	NULL
(	NULL
e	NULL
)	NULL
,	NULL
and	NULL
follicles	NULL
and	NULL
germinal	NULL
centers	NULL
of	NULL
the	NULL
lymph	NULL
nodes	NULL
(	NULL
A	NULL
)	NULL
.	NULL

¢	NULL
.	NULL

f	NULL
,	NULL
and	NULL
i	NULL
display	NULL
hematoxylin-	NULL
and	NULL
eosin-stained	NULL
sections	NULL
of	NULL
adjacent	NULL
regions	NULL
of	NULL
the	NULL
thymus	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
lymph	NULL
node	NULL
for	NULL
comparison	NULL
.	NULL

Magnification	NULL
,	NULL
5X	NULL
.	NULL

migrate	NULL
from	NULL
the	NULL
darkly	NULL
staining	NULL
thymic	NULL
cortex	NULL
to	NULL
the	NULL
pale	NULL
staining	NULL
medulla	NULL
where	NULL
single	NULL
positive	NULL
T	NULL
cells	NULL
undergo	NULL
negative	NULL
selection	NULL
.	NULL

In	NULL
the	NULL
spleen	NULL
,	NULL
Spi-B	NULL
mRNA	NULL
was	NULL
abundantly	NULL
expressed	NULL
throughout	NULL
the	NULL
white	NULL
pulp	NULL
,	NULL
except	NULL
the	NULL
center	NULL
portion	NULL
which	NULL
consists	NULL
of	NULL
arterioles	NULL
and	NULL
periarteriolar	NULL
lymphocyte	NULL
sheaths	NULL
(	NULL
PALS	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
e	NULL
)	NULL
.	NULL

The	NULL
PALS	NULL
contains	NULL
a	NULL
network	NULL
of	NULL
antigen-presenting	NULL
cells	NULL
,	NULL
such	NULL
as	NULL
interdigitat-ing	NULL
dendritic	NULL
cells	NULL
,	NULL
and	NULL
plasma	NULL
B	NULL
cells	NULL
.	NULL

B	NULL
cells	NULL
congregate	NULL
peripherally	NULL
to	NULL
the	NULL
PALS	NULL
in	NULL
primary	NULL
follicles	NULL
and	NULL
germinal	NULL
centers	NULL
.	NULL

The	NULL
outer	NULL
most	NULL
layer	NULL
of	NULL
the	NULL
white	NULL
pulp	NULL
is	NULL
the	NULL
marginal	NULL
zone	NULL
,	NULL
which	NULL
contains	NULL
T	NULL
and	NULL
B	NULL
lymphocytes	NULL
.	NULL

Spi-B	NULL
mRNA	NULL
is	NULL
present	NULL
in	NULL
cells	NULL
surrounding	NULL
the	NULL
arterioles	NULL
and	NULL
the	NULL
PALS	NULL
in	NULL
the	NULL
white	NULL
pulp	NULL
of	NULL
the	NULL
spleen	NULL
,	NULL
where	NULL
T	NULL
and	NULL
B	NULL
lym-phocytes	NULL
reside	NULL
.	NULL

In	NULL
lymph	NULL
nodes	NULL
,	NULL
Spi-B	NULL
is	NULL
present	NULL
in	NULL
the	NULL
primary	NULL
follicles	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
h	NULL
and	NULL
i	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

3	NULL
,	NULL
shows	NULL
in	NULL
situ	NULL
hybridization	NULL
analyses	NULL
with	NULL
the	NULL
thymus	NULL
(	NULL
6	NULL
)	NULL
,	NULL
spleen	NULL
(	NULL
e	NULL
)	NULL
,	NULL
and	NULL
lymph	NULL
nodes	NULL
(	NULL
h	NULL
)	NULL
at	NULL
a	NULL
higher	NULL
magnification	NULL
.	NULL

Spi-B	NULL
mRNA	NULL
was	NULL
present	NULL
in	NULL
the	NULL
periphery	NULL
of	NULL
the	NULL
thymic	NULL
medulla	NULL
and	NULL
the	NULL
germinal	NULL
centers	NULL
of	NULL
the	NULL
spleen	NULL
(	NULL
b	NULL
and	NULL
e	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

3	NULL
i	NULL
,	NULL
shows	NULL
a	NULL
resting	NULL
lymph	NULL
node	NULL
stained	NULL
with	NULL
hematoxylin	NULL
and	NULL
eosin	NULL
;	NULL
the	NULL
primary	NULL
follicles	NULL
reside	NULL
at	NULL
the	NULL
edge	NULL
.	NULL

Resting	NULL
B	NULL
cells	NULL
accumulate	NULL
in	NULL
the	NULL
follicles	NULL
which	NULL
clearly	NULL
express	NULL
Spi-B	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
h	NULL
)	NULL
.	NULL

The	NULL
spatial	NULL
pattern	NULL
of	NULL
expression	NULL
of	NULL
Spi-B	NULL
in	NULL
the	NULL
thymus	NULL
,	NULL
spleen	NULL
and	NULL
lymph	NULL
nodes	NULL
.	NULL

In	NULL
situ	NULL
hybridization	NULL
analyses	NULL
were	NULL
performed	NULL
using	NULL
a	NULL
ra	NULL
Spi-B	NULL
Expression	NULL
Is	NULL
Restricted	NULL
to	NULL
the	NULL
Thymus	NULL
and	NULL
Spleen	NULL
during	NULL
Murine	NULL
Embryogenesis	NULL
.	NULL

_	NULL
To	NULL
determine	NULL
the	NULL
temporal	NULL
and	NULL
spatial	NULL
patterns	NULL
of	NULL
expression	NULL
during	NULL
mammalian	NULL
develop-ment	NULL
,	NULL
in	NULL
situ	NULL
hybridization	NULL
experiments	NULL
were	NULL
performed	NULL
on	NULL
tissue	NULL
sections	NULL
obtained	NULL
from	NULL
mouse	NULL
embryos	NULL
at	NULL
various	NULL
gestational	NULL
stages	NULL
.	NULL

Sense	NULL
and	NULL
antisense	NULL
3	NULL
'	NULL
UTR	NULL
Spi-B	NULL
probes	NULL
were	NULL
hybridized	NULL
to	NULL
sections	NULL
of	NULL
day	NULL
7.5	NULL
,	NULL
8.5	NULL
,	NULL
10.5	NULL
,	NULL
14.5	NULL
,	NULL
16.5	NULL
,	NULL
and	NULL
19.5	NULL
mouse	NULL
embryos	NULL
.	NULL

The	NULL
results	NULL
are	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
show	NULL
that	NULL
Spi-B	NULL
mRNAs	NULL
were	NULL
detected	NULL
exclusively	NULL
in	NULL
fetal	NULL
thymus	NULL
and	NULL
spleen	NULL
.	NULL

Spi-B	NULL
expression	NULL
was	NULL
first	NULL
observed	NULL
in	NULL
the	NULL
day	NULL
14.5	NULL
thymus	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
a	NULL
and	NULL
c	NULL
)	NULL
.	NULL

All	NULL
tissues	NULL
in	NULL
day	NULL
7.5	NULL
,	NULL
8.5	NULL
,	NULL
and	NULL
10.5	NULL
embryos	NULL
failed	NULL
to	NULL
react	NULL
with	NULL
the	NULL
antisense	NULL
Spi-B	NULL
probe	NULL
and	NULL
gave	NULL
background	NULL
signals	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
with	NULL
the	NULL
control	NULL
sense	NULL
probe	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
b	NULL
.	NULL

Furthermore	NULL
,	NULL
all	NULL
other	NULL
tissues	NULL
in	NULL
the	NULL
day	NULL
14.5	NULL
embryo	NULL
were	NULL
negative	NULL
for	NULL
Spi-B	NULL
mRNA	NULL
production	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
a	NULL
)	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
neither	NULL
the	NULL
day	NULL
14.5	NULL
or	NULL
day	NULL
16.5	NULL
spleen	NULL
exhibited	NULL
Spi-B	NULL
gene	NULL
expression	NULL
.	NULL

However	NULL
,	NULL
when	NULL
sections	NULL
of	NULL
day	NULL
19.5	NULL
embryos	NULL
were	NULL
hybridized	NULL
to	NULL
the	NULL
Spi-B	NULL
probe	NULL
,	NULL
the	NULL
spleen	NULL
displayed	NULL
strong	NULL
signal	NULL
intensity	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
e	NULL
)	NULL
.	NULL

The	NULL
control	NULL
sense	NULL
probe	NULL
gave	NULL
the	NULL
expected	NULL
background	NULL
level	NULL
of	NULL
hybridization	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
d	NULL
)	NULL
.	NULL

In	NULL
206	NULL
Ets	NULL
Protein	NULL
Spi-B	NULL
Is	NULL
Expressed	NULL
Exclusively	NULL
in	NULL
B	NULL
Cells	NULL
and	NULL
T	NULL
Cells	NULL
i	NULL
%	NULL
|	NULL
*y	NULL
a	NULL
“	NULL
A	NULL
K	NULL
Figure	NULL
3	NULL
.	NULL

-	NULL
The	NULL
spatial	NULL
pattern	NULL
of	NULL
expression	NULL
of	NULL
Spi~-B	NULL
in	NULL
adult	NULL
thymus	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
lymph	NULL
nodes	NULL
.	NULL

In	NULL
situ	NULL
hybridization	NULL
was	NULL
performed	NULL
using	NULL
radiolabeled	NULL
sense	NULL
Spi-B	NULL
riboprobe	NULL
(	NULL
a	NULL
,	NULL
d	NULL
,	NULL
and	NULL
g	NULL
)	NULL
and	NULL
antisense	NULL
Spi-B	NULL
riboprobe	NULL
(	NULL
b	NULL
,	NULL
e	NULL
,	NULL
and	NULL
h	NULL
)	NULL
.	NULL

c	NULL
,	NULL
f	NULL
,	NULL
and	NULL
i	NULL
depict	NULL
hematoxylin-	NULL
and	NULL
eosin-stained	NULL
adjacent	NULL
sections	NULL
of	NULL
the	NULL
thymus	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
lymph	NULL
node	NULL
,	NULL
respectively	NULL
.	NULL

Magnification	NULL
,	NULL
10	NULL
X	NULL
.	NULL

Figure	NULL
4	NULL
.	NULL

-	NULL
The	NULL
temporal	NULL
and	NULL
spacial	NULL
patterns	NULL
of	NULL
Spi-B	NULL
expression	NULL
during	NULL
murine	NULL
embryonic	NULL
development	NULL
.	NULL

In	NULL
situ	NULL
hybridization	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
3	NULL
'	NULL
UTR	NULL
sense	NULL
and	NULL
antisense	NULL
Spi-B	NULL
riboprobes	NULL
on	NULL
day	NULL
14.5	NULL
and	NULL
19.5	NULL
mouse	NULL
embryo	NULL
tissue	NULL
sections	NULL
;	NULL
a	NULL
shows	NULL
hybridization	NULL
to	NULL
the	NULL
antisense	NULL
probe	NULL
.	NULL

Magnification	NULL
,	NULL
12.5	NULL
X	NULL
.	NULL

Sense	NULL
and	NULL
antisense	NULL
Spi-B	NULL
riboprobes	NULL
were	NULL
hybridized	NULL
to	NULL
day	NULL
14.5	NULL
embryonic	NULL
tissues	NULL
(	NULL
b	NULL
and	NULL
c	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Magnification	NULL
,	NULL
25	NULL
X.	NULL
d	NULL
and	NULL
e	NULL
show	NULL
hybridization	NULL
to	NULL
day	NULL
19.5	NULL
mouse	NULL
embryo	NULL
tissue	NULL
sections	NULL
with	NULL
sense	NULL
and	NULL
antisense	NULL
Spi-B	NULL
riboprobes	NULL
,	NULL
respectively	NULL
.	NULL

Magnification	NULL
,	NULL
25	NULL
X	NULL
.	NULL

Only	NULL
the	NULL
thymus	NULL
and	NULL
spleen	NULL
exhibited	NULL
Spi-B	NULL
mRNA	NULL
expression	NULL
during	NULL
development	NULL
.	NULL

the	NULL
day	NULL
19.5	NULL
embryo	NULL
,	NULL
Spi-B	NULL
hybridization	NULL
was	NULL
detected	NULL
only	NULL
in	NULL
the	NULL
thymus	NULL
and	NULL
spleen	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
Spi-B	NULL
gene	NULL
expression	NULL
is	NULL
highly	NULL
tissue	NULL
restricted	NULL
and	NULL
can	NULL
only	NULL
be	NULL
detected	NULL
in	NULL
the	NULL
developing	NULL
lymphoid	NULL
organs	NULL
of	NULL
the	NULL
mouse	NULL
embryo	NULL
.	NULL

Spi-B	NULL
Expression	NULL
Is	NULL
Developmentally	NULL
Regulated	NULL
during	NULL
T	NULL
Cell	NULL
and	NULL
B	NULL
Cell	NULL
Development	NULL
.	NULL

-	NULL
To	NULL
further	NULL
explore	NULL
Spi-B	NULL
expression	NULL
during	NULL
B	NULL
cell	NULL
maturation	NULL
,	NULL
immortalized	NULL
B	NULL
cell	NULL
lines	NULL
representing	NULL
different	NULL
developmental	NULL
stages	NULL
were	NULL
studied	NULL
.	NULL

Low	NULL
level	NULL
Spi-B	NULL
expression	NULL
was	NULL
detected	NULL
in	NULL
pro-B	NULL
cells	NULL
(	NULL
NFS	NULL
70/c10	NULL
cells	NULL
;	NULL
Fig	NULL
.	NULL

5	NULL
A	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
higher	NULL
levels	NULL
in	NULL
one	NULL
pre-B	NULL
cell	NULL
line	NULL
(	NULL
38	NULL
B9	NULL
cells	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
and	NULL
dramatically	NULL
increased	NULL
levels	NULL
in	NULL
mature	NULL
B	NULL
cells	NULL
such	NULL
as	NULL
A20.1	NULL
and	NULL
WEHI	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Purified	NULL
splenic	NULL
B	NULL
cells	NULL
exhibited	NULL
high	NULL
levels	NULL
of	NULL
Spi-B	NULL
as	NULL
well	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

Low	NULL
levels	NULL
of	NULL
Spi-B	NULL
mRNAs	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
immature	NULL
T	NULL
cell	NULL
line	NULL
EL-4	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
and	NULL
column	NULL
enriched	NULL
,	NULL
anti-J11D/complement	NULL
depleted	NULL
splenic	NULL
T	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
Spi-B	NULL
transcription	NULL
changes	NULL
during	NULL
T	NULL
cell	NULL
maturation	NULL
,	NULL
T	NULL
cells	NULL
were	NULL
sorted	NULL
into	NULL
the	NULL
CD4~	NULL
CD8~	NULL
(	NULL
double	NULL
negative	NULL
:	NULL
DN	NULL
)	NULL
,	NULL
CD4*	NULL
CD8*	NULL
(	NULL
double	NULL
positive	NULL
:	NULL
DP	NULL
)	NULL
,	NULL
and	NULL
CD4*	NULL
or	NULL
CD8	NULL
*	NULL
single	NULL
positive	NULL
(	NULL
SP	NULL
)	NULL
pop-ulations	NULL
.	NULL

Interestingly	NULL
,	NULL
Spi-B	NULL
mRNA	NULL
was	NULL
most	NULL
abundant	NULL
in	NULL
the	NULL
CD4~	NULL
CD8~	NULL
``	NULL
double	NULL
negative	NULL
``	NULL
population	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
C	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
Rag2~-	NULL
thymi	NULL
express	NULL
higher	NULL
levels	NULL
than	NULL
those	NULL
obtained	NULL
from	NULL
C57BL/6	NULL
mice	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Rag	NULL
2~~-	NULL
thymi	NULL
have	NULL
previously	NULL
been	NULL
shown	NULL
to	NULL
contain	NULL
no	NULL
DP	NULL
or	NULL
SP	NULL
T	NULL
cells	NULL
and	NULL
to	NULL
contain	NULL
essentially	NULL
98	NULL
%	NULL
DN	NULL
cells	NULL
(	NULL
22	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
Spi-B	NULL
expression	NULL
being	NULL
highest	NULL
in	NULL
DN	NULL
T	NULL
cell	NULL
precursors	NULL
.	NULL

Furthermore	NULL
,	NULL
Spi-B	NULL
expression	NULL
was	NULL
higher	NULL
in	NULL
the	NULL
immature	NULL
T	NULL
cell	NULL
line	NULL
,	NULL
EL-4	NULL
,	NULL
than	NULL
the	NULL
mature	NULL
T	NULL
cell	NULL
line	NULL
,	NULL
RMA	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
A4	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
Spi-B	NULL
gene	NULL
expression	NULL
increases	NULL
during	NULL
B	NULL
cell	NULL
maturation	NULL
and	NULL
decreases	NULL
during	NULL
T	NULL
cell	NULL
maturation	NULL
.	NULL

Surprisingly	NULL
,	NULL
some	NULL
PU.1	NULL
expression	NULL
was	NULL
also	NULL
detected	NULL
in	NULL
the	NULL
CD4~	NULL
CD8~	NULL
sorted	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
C	NULL
)	NULL
,	NULL
although	NULL
it	NULL
was	NULL
completely	NULL
absent	NULL
in	NULL
a	NULL
number	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
lines	NULL
examined	NULL
by	NULL
RT-PCR	NULL
analyses	NULL
(	NULL
Jurkat	NULL
,	NULL
H9	NULL
,	NULL
Molt	NULL
3	NULL
)	NULL
and	NULL
purified	NULL
human	NULL
peripheral	NULL
T	NULL
cells	NULL
{	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

RT-PCR	NULL
assays	NULL
for	NULL
M-CSF	NULL
receptor	NULL
expression	NULL
indicated	NULL
that	NULL
the	NULL
RNA	NULL
samples	NULL
contained	NULL
no	NULL
contaminating	NULL
monocytic	NULL
cells	NULL
{	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
it	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
Spi-B	NULL
was	NULL
found	NULL
in	NULL
EL-4	NULL
T	NULL
cells	NULL
,	NULL
thymocytes	NULL
,	NULL
and	NULL
the	NULL
thymus	NULL
when	NULL
these	NULL
samples	NULL
were	NULL
run	NULL
separately	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
B	NULL
)	NULL
.	NULL

Spi-B	NULL
Is	NULL
Highly	NULL
Expressed	NULL
in	NULL
Human	NULL
B	NULL
Cells	NULL
and	NULL
Some	NULL
T	NULL
Cells	NULL
at	NULL
Both	NULL
the	NULL
RNA	NULL
and	NULL
Protein	NULL
Levels	NULL
.	NULL

-	NULL
Several	NULL
human	NULL
cell	NULL
lines	NULL
were	NULL
examined	NULL
for	NULL
Spi-B	NULL
expression	NULL
by	NULL
poly-A*	NULL
RNA	NULL
Northern	NULL
blot	NULL
analysis	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Spi-B	NULL
RNA	NULL
was	NULL
detected	NULL
in	NULL
clone	NULL
13	NULL
B	NULL
cells	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
but	NULL
was	NULL
not	NULL
present	NULL
in	NULL
monocytic	NULL
cells	NULL
such	NULL
as	NULL
U937	NULL
and	NULL
K562	NULL
and	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
lanes	NULL
3-5	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
TPA	NULL
treatment	NULL
of	NULL
U937	NULL
cells	NULL
(	NULL
which	NULL
converts	NULL
them	NULL
from	NULL
monoblasts	NULL
to	NULL
monocytes	NULL
)	NULL
did	NULL
not	NULL
induce	NULL
Spi-B	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Spi-B	NULL
expression	NULL
was	NULL
not	NULL
apparent	NULL
in	NULL
the	NULL
non-hematopoietic	NULL
epithelial	NULL
cell	NULL
line	NULL
HeLa	NULL
or	NULL
Hep	NULL
G2	NULL
hepatic	NULL
cells	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
tissue	NULL
specificity	NULL
of	NULL
Spi-B	NULL
protein	NULL
expression	NULL
and	NULL
to	NULL
confirm	NULL
that	NULL
the	NULL
level	NULL
of	NULL
gene	NULL
expression	NULL
correlated	NULL
with	NULL
the	NULL
level	NULL
of	NULL
protein	NULL
expression	NULL
,	NULL
Western	NULL
blot	NULL
analyses	NULL
were	NULL
performed	NULL
.	NULL

Polyclonal	NULL
antiserum	NULL
raised	NULL
A	NULL
m	NULL
io	NULL
-	NULL
L	NULL
2	NULL
MO	NULL
m	NULL
-	NULL
m	NULL
5	NULL
o	NULL
3	NULL
2	NULL
2	NULL
o	NULL
g	NULL
8	NULL
3	NULL
S	NULL
6	NULL
5	NULL
a.	NULL
o.	NULL
a=	NULL
4	NULL
E	NULL
€	NULL
4	NULL
m-	NULL
.	NULL

~	NULL
Cp	NULL
Cj	NULL
-..	NULL
1.4	NULL
KCBS	NULL
-	NULL
nea	NULL
dhs	NULL
guage	NULL
guy	NULL
@	NULL
<	NULL
<	NULL
-	NULL
GADPH	NULL
B	NULL
-o-	NULL
g	NULL
2	NULL
+-	NULL
E	NULL
”	NULL
i	NULL
=	NULL
§	NULL
f	NULL
&	NULL
C	NULL
5	NULL
$	NULL
2	NULL
2	NULL
E	NULL
s	NULL
f	NULL
i-|	NULL
wae	NULL
-	NULL
<	NULL
-	NULL
Spi-B	NULL
Hagz	NULL
'	NULL
f	NULL
'	NULL
BL/6	NULL
Pos	NULL
control	NULL
-	NULL
RT	NULL
bt	NULL
DP	NULL
CD4*	NULL
cpst	NULL
Spi-B	NULL
(	NULL
520	NULL
bp	NULL
)	NULL
PU.1	NULL
(	NULL
610	NULL
bp	NULL
)	NULL
his	NULL
commie	NULL
somas	NULL
coons	NULL
Ally	NULL
hl	NULL
(	NULL
ste	NULL
B-actin	NULL
(	NULL
934	NULL
bp	NULL
)	NULL
Figure	NULL
5	NULL
.	NULL

-	NULL
Spi-B	NULL
mRNA	NULL
expression	NULL
during	NULL
B	NULL
cell	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
top	NULL
panel	NULL
shows	NULL
a	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
RNA	NULL
samples	NULL
obtained	NULL
from	NULL
murine	NULL
B	NULL
and	NULL
T	NULL
cell	NULL
lines	NULL
and	NULL
purified	NULL
splenic	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

B	NULL
cell	NULL
lines	NULL
analyzed	NULL
include	NULL
NFS	NULL
70/c10	NULL
cells	NULL
(	NULL
Pro	NULL
B	NULL
)	NULL
,	NULL
38	NULL
B9	NULL
cells	NULL
and	NULL
70Z7/3	NULL
cells	NULL
(	NULL
Pre	NULL
B	NULL
)	NULL
,	NULL
and	NULL
A20.1	NULL
and	NULL
WEHI	NULL
cells	NULL
(	NULL
mature	NULL
B	NULL
)	NULL
.	NULL

T	NULL
cell	NULL
lines	NULL
examined	NULL
include	NULL
mature	NULL
RMA	NULL
T	NULL
cells	NULL
(	NULL
isolated	NULL
from	NULL
a	NULL
lymphoma	NULL
)	NULL
and	NULL
immature	NULL
EL-4	NULL
T	NULL
cells	NULL
(	NULL
isolated	NULL
from	NULL
a	NULL
thymoma	NULL
)	NULL
.	NULL

The	NULL
bottom	NULL
panel	NULL
displays	NULL
hybridization	NULL
to	NULL
the	NULL
control	NULL
GAPDH	NULL
probe	NULL
.	NULL

(	NULL
B	NULL
)	NULL
RNA	NULL
samples	NULL
from	NULL
A	NULL
run	NULL
on	NULL
a	NULL
separate	NULL
Northern	NULL
analysis	NULL
to	NULL
demonstrate	NULL
that	NULL
weak	NULL
hybridization	NULL
detected	NULL
in	NULL
T	NULL
cells	NULL
was	NULL
not	NULL
obtained	NULL
by	NULL
contamination	NULL
from	NULL
adjacent	NULL
lanes	NULL
exhibiting	NULL
strong	NULL
Spi-B	NULL
expression	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
top	NULL
panel	NULL
shows	NULL
RT-PCR	NULL
assays	NULL
for	NULL
Spi-B	NULL
expression	NULL
in	NULL
FACS®-sorted	NULL
CD47	NULL
CD8~	NULL
(	NULL
DN	NULL
)	NULL
T	NULL
cells	NULL
,	NULL
CD4+*	NULL
CD8*	NULL
(	NULL
DP	NULL
)	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
CD4+	NULL
and	NULL
CD8*	NULL
single	NULL
positive	NULL
T	NULL
cells	NULL
.	NULL

Also	NULL
shown	NULL
are	NULL
RT-PCR	NULL
assays	NULL
performed	NULL
on	NULL
RNA	NULL
samples	NULL
from	NULL
RAG2~~	NULL
and	NULL
C57BL/6	NULL
thymi	NULL
and	NULL
A20.1	NULL
mature	NULL
B	NULL
cells	NULL
(	NULL
positive	NULL
control	NULL
)	NULL
.	NULL

The	NULL
final	NULL
lane	NULL
shows	NULL
a	NULL
negative	NULL
control	NULL
reaction	NULL
containing	NULL
A20.1	NULL
B	NULL
cell	NULL
RNA	NULL
with	NULL
no	NULL
reverse	NULL
transcriptase	NULL
(	NULL
RT	NULL
)	NULL
.	NULL

The	NULL
middle	NULL
and	NULL
bottom	NULL
panels	NULL
depict	NULL
RT-PCR	NULL
assays	NULL
performed	NULL
on	NULL
the	NULL
same	NULL
samples	NULL
for	NULL
PU.1	NULL
and	NULL
mouse	NULL
b-actin	NULL
expression	NULL
.	NULL

RT-PCR	NULL
products	NULL
generated	NULL
for	NULL
Spi-B	NULL
,	NULL
PU.1	NULL
,	NULL
and	NULL
B-actin	NULL
mRNAs	NULL
were	NULL
520	NULL
,	NULL
610	NULL
,	NULL
and	NULL
934	NULL
bp	NULL
,	NULL
respectively	NULL
.	NULL

against	NULL
human	NULL
Spi-B-GST	NULL
fusion	NULL
protein	NULL
was	NULL
specific	NULL
for	NULL
in	NULL
vitro-translated	NULL
(	NULL
IVT	NULL
)	NULL
human	NULL
Spi-B	NULL
in	NULL
immunoblotting	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
pre-immune	NULL
sera	NULL
failed	NULL
to	NULL
bind	NULL
IVT	NULL
Spi-B	NULL
,	NULL
PU.1	NULL
,	NULL
and	NULL
JunB	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
A	NULL
,	NULL
lanes	NULL
1-3	NULL
)	NULL
,	NULL
while	NULL
polyclonal	NULL
antisera	NULL
for	NULL
Spi-B-GST	NULL
specifically	NULL
recognized	NULL
IVT	NULL
Spi-B	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
it	NULL
did	NULL
not	NULL
cross-react	NULL
with	NULL
IVT	NULL
PU.1	NULL
,	NULL
c-Fos	NULL
,	NULL
or	NULL
JunB	NULL
(	NULL
lanes	NULL
5-7	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
208	NULL
Ets	NULL
Protein	NULL
Spi-B	NULL
Is	NULL
Expressed	NULL
Exclusively	NULL
in	NULL
B	NULL
Cells	NULL
and	NULL
T	NULL
Cells	NULL
A	NULL
o	NULL
grip-NESG	NULL
ommwfnd	NULL
2	NULL
a	NULL
a	NULL
im	NULL
5	NULL
0	NULL
0	NULL
0	NULL
3	NULL
5	NULL
¥	NULL
53	NULL
IE	NULL
I	NULL
3.7	NULL
2.8	NULL
Spi-B	NULL
1-5-N	NULL
1.4	NULL
-	NULL
MIR	NULL
0~~	NULL
Wie	NULL
HHB	NULL
w	NULL
-	NULL
>	NULL
-	NULL
GAPDH	NULL
Figure	NULL
6	NULL
.	NULL

_	NULL
A	NULL
Poly-A*	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
Spi-B	NULL
expression	NULL
in	NULL
human	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
top	NULL
panel	NULL
shows	NULL
hybridization	NULL
to	NULL
a	NULL
radiolabeled	NULL
3	NULL
'	NULL
UTR	NULL
probe	NULL
of	NULL
the	NULL
human	NULL
Spi-B	NULL
cDNA	NULL
of	NULL
clone	NULL
13	NULL
B	NULL
cell	NULL
,	NULL
U937	NULL
mono-blast	NULL
,	NULL
K562	NULL
erythroid/myeloid	NULL
cells	NULL
,	NULL
Jurkat	NULL
T	NULL
cell	NULL
,	NULL
HepG2	NULL
hepatoma	NULL
,	NULL
and	NULL
HeLa	NULL
cervical	NULL
carcinoma	NULL
cell	NULL
RNA	NULL
samples	NULL
.	NULL

3.7	NULL
,	NULL
2.8	NULL
,	NULL
and	NULL
1.5-kb	NULL
RNA	NULL
species	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
bottom	NULL
panel	NULL
shows	NULL
hybridization	NULL
to	NULL
the	NULL
control	NULL
GAPDH	NULL
radiolabeled	NULL
probe	NULL
.	NULL

the	NULL
antisera	NULL
did	NULL
not	NULL
cross	NULL
react	NULL
with	NULL
murine	NULL
Spi-B	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
46-kd	NULL
Spi-B	NULL
protein	NULL
was	NULL
detected	NULL
in	NULL
all	NULL
seven	NULL
B	NULL
cell	NULL
lines	NULL
examined	NULL
(	NULL
Clone	NULL
13	NULL
,	NULL
Raji	NULL
,	NULL
CCFR-SB	NULL
,	NULL
RPMI	NULL
7666	NULL
,	NULL
RPMI	NULL
1788	NULL
,	NULL
IM-9	NULL
,	NULL
and	NULL
WIL2-NS	NULL
)	NULL
,	NULL
and	NULL
one	NULL
of	NULL
the	NULL
three	NULL
T	NULL
cell	NULL
lines	NULL
(	NULL
H9	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
A4	NULL
and	NULL
B	NULL
)	NULL
.	NULL

No	NULL
Spi-B	NULL
protein	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
monocytic	NULL
cell	NULL
lines	NULL
K562	NULL
and	NULL
U937	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
A	NULL
,	NULL
lanes	NULL
9	NULL
and	NULL
11	NULL
)	NULL
or	NULL
HeLa	NULL
epithelial	NULL
cells	NULL
(	NULL
lane	NULL
12	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
protein	NULL
expression	NULL
correlated	NULL
with	NULL
the	NULL
abundance	NULL
of	NULL
Spi-B	NULL
mRNAs	NULL
.	NULL

It	NULL
is	NULL
not	NULL
surprising	NULL
that	NULL
Clone	NULL
13	NULL
and	NULL
H9	NULL
express	NULL
Spi-B	NULL
proteins	NULL
,	NULL
since	NULL
they	NULL
both	NULL
contain	NULL
high	NULL
levels	NULL
of	NULL
Spi-B	NULL
mRNAs	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
H9	NULL
T	NULL
cells	NULL
are	NULL
less	NULL
mature	NULL
than	NULL
either	NULL
Jurkat	NULL
or	NULL
Molt3	NULL
cells	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
IM-9	NULL
cells	NULL
are	NULL
less	NULL
mature	NULL
than	NULL
Raji	NULL
,	NULL
CCRF-SB	NULL
,	NULL
RPM1	NULL
7666	NULL
,	NULL
RPM1	NULL
1788	NULL
cells	NULL
,	NULL
and	NULL
WIL2-NSB	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
Spi-B	NULL
expression	NULL
appears	NULL
to	NULL
decrease	NULL
as	NULL
human	NULL
T	NULL
cells	NULL
mature	NULL
and	NULL
increase	NULL
as	NULL
human	NULL
B	NULL
cells	NULL
mature	NULL
,	NULL
as	NULL
was	NULL
noted	NULL
in	NULL
murine	NULL
lymphocytes	NULL
.	NULL

Finally	NULL
,	NULL
no	NULL
Spi-B	NULL
protein	NULL
was	NULL
detected	NULL
in	NULL
peripheral	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Spi-B	NULL
Specifically	NULL
Binds	NULL
to	NULL
Putative	NULL
PU.1	NULL
Binding	NULL
Sites	NULL
in	NULL
Monocytic	NULL
and	NULL
B	NULL
Cell	NULL
Target	NULL
Genes	NULL
.	NULL

A	NULL
growing	NULL
number	NULL
of	NULL
PU.1	NULL
target	NULL
genes	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
monocytic	NULL
and	NULL
B	NULL
cell	NULL
lines	NULL
,	NULL
including	NULL
c-fes	NULL
,	NULL
the	NULL
M-CSF	NULL
receptor	NULL
,	NULL
and	NULL
the	NULL
high	NULL
affinity	NULL
receptor	NULL
for	NULL
Fc	NULL
fragments	NULL
(	NULL
FcyR	NULL
)	NULL
in	NULL
monocytes	NULL
and	NULL
]	NULL
chain	NULL
and	NULL
«	NULL
and	NULL
A	NULL
immunoglobulin	NULL
light	NULL
chains	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

To	NULL
assess	NULL
PU.1	NULL
versus	NULL
Spi-B	NULL
DNA-binding	NULL
specificity	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
were	NULL
performed	NULL
with	NULL
IVT	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
proteins	NULL
.	NULL

EMSAs	NULL
were	NULL
performed	NULL
so	NULL
that	NULL
equal	NULL
amounts	NULL
of	NULL
IVT	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
proteins	NULL
were	NULL
loaded	NULL
in	NULL
each	NULL
reaction	NULL
to	NULL
compare	NULL
the	NULL
approximate	NULL
binding	NULL
affinity	NULL
of	NULL
these	NULL
two	NULL
proteins	NULL
to	NULL
different	NULL
PU.1	NULL
binding	NULL
sites	NULL
.	NULL

Under	NULL
our	NULL
experimental	NULL
conditions	NULL
,	NULL
no	NULL
209	NULL
Su	NULL
et	NULL
al	NULL
.	NULL

PI	NULL
a-Spi-B	NULL
1	NULL
1	NULL
1	NULL
as	NULL
§	NULL
us	NULL
G	NULL
5	NULL
;	NULL
_	NULL
$	NULL
63	NULL
8	NULL
a	NULL
$	NULL
n	NULL
9	NULL
5	NULL
©	NULL
€	NULL
am	NULL
J	NULL
55E5EE	NULL
EEG	NULL
p	NULL
1	NULL
s	NULL
2	NULL
22	NULL
o	NULL
¥	NULL
%	NULL
J	NULL
T	NULL
-	NULL
66	NULL
Spi-B-	NULL
»	NULL
am	NULL
plies	NULL
.	NULL

-	NULL
46	NULL
B	NULL
a-Spi-B	NULL
1	NULL
1	NULL
m	NULL
$	NULL
$	NULL
2	NULL
a	NULL
p	NULL
n	NULL
2	NULL
8	NULL
w	NULL
L	NULL
I	NULL
|	NULL
T	NULL
0	NULL
,	NULL
s	NULL
igs	NULL
.sp	NULL
f	NULL
=	NULL
5	NULL
S	NULL
8	NULL
&	NULL
Bs	NULL
s	NULL
2	NULL
8	NULL
3	NULL
-	NULL
66	NULL
--	NULL
+	NULL
Ga	NULL
-	NULL
#	NULL
2	NULL
-	NULL
46	NULL
-	NULL
30	NULL
Figure	NULL
7	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
Spi-B	NULL
protein	NULL
in	NULL
human	NULL
cell	NULL
lines	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Pre-immune	NULL
sera	NULL
and	NULL
anti-Spi-B	NULL
antiserum	NULL
was	NULL
reacted	NULL
with	NULL
IVT	NULL
human	NULL
Spi-B	NULL
,	NULL
PU.1	NULL
,	NULL
and	NULL
Jun	NULL
B	NULL
proteins	NULL
or	NULL
IVT	NULL
human	NULL
Spi-B	NULL
,	NULL
PU.1	NULL
,	NULL
and	NULL
c-Fos	NULL
proteins	NULL
.	NULL

Total	NULL
cell	NULL
lysates	NULL
from	NULL
clone	NULL
13	NULL
,	NULL
K562	NULL
,	NULL
Jurkat	NULL
,	NULL
U937	NULL
,	NULL
and	NULL
Hela	NULL
cells	NULL
are	NULL
also	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Anti-Spi-B	NULL
antiserum	NULL
was	NULL
reacted	NULL
with	NULL
a	NULL
Western	NULL
blot	NULL
of	NULL
lysates	NULL
obtained	NULL
from	NULL
Raji	NULL
,	NULL
CCRF-SB	NULL
,	NULL
RPMI	NULL
1666	NULL
,	NULL
RPMI	NULL
1788	NULL
,	NULL
IM-9	NULL
,	NULL
WIL2-NS	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
H9	NULL
and	NULL
Molt3	NULL
T	NULL
cells	NULL
(	NULL
IVT	NULL
human	NULL
Spi-B	NULL
was	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
)	NULL
.	NULL

The	NULL
size	NULL
of	NULL
molecular	NULL
mass	NULL
standards	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
left	NULL
.	NULL

proteins	NULL
other	NULL
than	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
in	NULL
the	NULL
TNT	NULL
reticulocyte	NULL
lysate	NULL
bound	NULL
to	NULL
the	NULL
labeled	NULL
oligonucleotides	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
both	NULL
IVT	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
(	NULL
which	NULL
yielded	NULL
a	NULL
slower	NULL
mobility	NULL
EMSA	NULL
complex	NULL
)	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
specific	NULL
in	NULL
a	NULL
series	NULL
of	NULL
competition	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
A	NULL
)	NULL
.	NULL

The	NULL
wild-type	NULL
cold	NULL
competitor	NULL
oligonucleotides	NULL
competed	NULL
with	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
binding	NULL
activities	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
5	NULL
,	NULL
8	NULL
,	NULL
and	NULL
11	NULL
)	NULL
,	NULL
but	NULL
not	NULL
competitor	NULL
oligonucleotides	NULL
harboring	NULL
mutations	NULL
in	NULL
the	NULL
core	NULL
sequence	NULL
of	NULL
each	NULL
PU.1	NULL
binding	NULL
site	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
9	NULL
,	NULL
and	NULL
12	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
activity	NULL
of	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
was	NULL
compared	NULL
for	NULL
oligonucleotides	NULL
derived	NULL
from	NULL
the	NULL
c-fes	NULL
promoter	NULL
and	NULL
the	NULL
SV	NULL
40	NULL
enhancer	NULL
.	NULL

The	NULL
binding	NULL
activity	NULL
of	NULL
Spi-B	NULL
to	NULL
the	NULL
PU.1-binding	NULL
site	NULL
in	NULL
SV40	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
PU.1	NULL
,	NULL
however	NULL
Spi-B	NULL
appeared	NULL
to	NULL
bind	NULL
more	NULL
weakly	NULL
to	NULL
the	NULL
c-fes	NULL
promoter	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

8	NULL
A	NULL
,	NULL
lanes	NULL
1	NULL
,	NULL
4	NULL
,	NULL
7	NULL
,	NULL
and	NULL
10	NULL
)	NULL
.	NULL

Spi-B	NULL
bound	NULL
specifically	NULL
and	NULL
with	NULL
similar	NULL
affinity	NULL
to	NULL
PU.1	NULL
to	NULL
the	NULL
sites	NULL
in	NULL
the	NULL
M-CSFR	NULL
and	NULL
FCyRI	NULL
promoters	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
B	NULL
,	NULL
lanes	NULL
1-8	NULL
)	NULL
.	NULL

However	NULL
,	NULL
Spi-B	NULL
bound	NULL
to	NULL
the	NULL
PU	NULL
sites	NULL
in	NULL
J	NULL
chain	NULL
promoter	NULL
and	NULL
the	NULL
3	NULL
'	NULL
enhancer	NULL
of	NULL
Igx	NULL
with	NULL
A	NULL
IVT	NULL
PUA	NULL
:	NULL
+	NULL
[	NULL
+	NULL
]	NULL
+	NULL
]	NULL
-|	NULL
-|	NULL
«	NULL
|	NULL
+	NULL
|	NULL
+	NULL
[	NULL
+	NULL
|	NULL
-|	NULL
-	NULL
[	NULL
+	NULL
IVT	NULL
Spi-B	NULL
:	NULL
=	NULL
|=	NULL
]	NULL
=	NULL
|+	NULL
]	NULL
+	NULL
[	NULL
4+	NULL
]	NULL
=|	NULL
-|	NULL
-	NULL
|+	NULL
]	NULL
+	NULL
|+	NULL
Competitor	NULL
:	NULL
|	NULL
-	NULL
[	NULL
wt	NULL
mt	NULL
]	NULL
-	NULL
|wtimt	NULL
]	NULL
-	NULL
-	NULL
|	NULL
wt	NULL
Imt	NULL
3	NULL
;	NULL
%	NULL
®	NULL
``	NULL
``	NULL
4.40	NULL
%	NULL
~*	NULL
[	NULL
123456739101112I	NULL
1	NULL
Probe	NULL
:	NULL
c-fes	NULL
SV40	NULL
IVT	NULL
PUA	NULL
:	NULL
+	NULL
[	NULL
+	NULL
|-	NULL
|=	NULL
=|	NULL
-|	NULL
+	NULL
]	NULL
4+	NULL
]	NULL
-|-|4+|4+|	NULL
-	NULL
+	NULL
|	NULL
+	NULL
|	NULL
-|-IVT	NULL
Spi-B	NULL
:	NULL
-|-	NULL
1+	NULL
]	NULL
+	NULL
|-	NULL
|-	NULL
|	NULL
+	NULL
]	NULL
4+	NULL
]	NULL
-	NULL
|	NULL
[	NULL
-	NULL
]	NULL
+	NULL
]	NULL
+	NULL
]	NULL
-|-|+	NULL
-|-	NULL
|+|+	NULL
Competitor	NULL
:	NULL
|	NULL
-	NULL
\	NULL
wt	NULL
]	NULL
-	NULL
|	NULL
wt|	NULL
-	NULL
|wt|	NULL
-	NULL
|	NULL
wt|	NULL
-	NULL
(	NULL
wt	NULL
)	NULL
-	NULL
|wt|	NULL
-	NULL
|wt|	NULL
-	NULL
|wt|	NULL
|	NULL
-	NULL
Figure	NULL
8	NULL
.	NULL

-	NULL
EMSAs	NULL
of	NULL
Spi-B	NULL
binding	NULL
to	NULL
published	NULL
PU.1	NULL
binding	NULL
sites	NULL
in	NULL
macrophage	NULL
and	NULL
B	NULL
cell	NULL
target	NULL
%	NULL
-	NULL
*-	NULL
genes	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Radiolabeled	NULL
c-fes	NULL
and	NULL
SV40	NULL
enhancer	NULL
|1	NULL
2	NULL
3	NULL
4	NULL
}	NULL
5	NULL
6	NULL
7	NULL
81	NULL
9	NULL
10	NULL
1112	NULL
{	NULL
1314	NULL
15	NULL
16	NULL
)	NULL
(	NULL
1718	NULL
19	NULL
20	NULL
;	NULL
oligonucleotides	NULL
were	NULL
used	NULL
in	NULL
gel	NULL
retardation	NULL
assays	NULL
with	NULL
IVT	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
a	NULL
200-300	NULL
ng	NULL
wild	NULL
type	NULL
(	NULL
wt	NULL
)	NULL
or	NULL
PU.1	NULL
site	NULL
mutant	NULL
(	NULL
mmf	NULL
)	NULL
oligonucleotides	NULL
were	NULL
added	NULL
to	NULL
the	NULL
DNA-binding	NULL
assays	NULL
.	NULL

The	NULL
arrows	NULL
indicate	NULL
the	NULL
rapidly	NULL
migrating	NULL
PU.1/DNA	NULL
complexes	NULL
and	NULL
slowly	NULL
migrating	NULL
Spi-B/DNA	NULL
complexes	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Radiolabeled	NULL
M-CSFR	NULL
promoter	NULL
,	NULL
FcyRI	NULL
promoter	NULL
,	NULL
B-globin	NULL
intron	NULL
,	NULL
]	NULL
chain	NULL
promoter	NULL
,	NULL
and	NULL
Igx	NULL
3	NULL
'	NULL
enhancer	NULL
oligonucleotides	NULL
were	NULL
used	NULL
in	NULL
gel	NULL
retardation	NULL
assays	NULL
.	NULL

The	NULL
arrows	NULL
indicate	NULL
the	NULL
various	NULL
PU.1/DNA	NULL
and	NULL
Spi-B/	NULL
Probe	NULL
:	NULL
M-CSFR	NULL
FoyR	NULL
fi-globin	NULL
lower	NULL
affinity	NULL
than	NULL
PU.1	NULL
(	NULL
lanes	NULL
13-20	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
both	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
bind	NULL
strongly	NULL
to	NULL
the	NULL
B-globin	NULL
intervening	NULL
sequence	NULL
2	NULL
,	NULL
(	NULL
lanes	NULL
9-12	NULL
)	NULL
.	NULL

Table	NULL
1	NULL
summarizes	NULL
the	NULL
results	NULL
of	NULL
the	NULL
binding	NULL
assays	NULL
performed	NULL
and	NULL
displays	NULL
the	NULL
oligonucleotide	NULL
sequences	NULL
used	NULL
.	NULL

We	NULL
observed	NULL
strong	NULL
Spi-B-binding	NULL
to	NULL
the	NULL
PU.1	NULL
sites	NULL
in	NULL
B-globin	NULL
,	NULL
M-CSFR	NULL
,	NULL
FCyRI	NULL
and	NULL
weaker	NULL
binding	NULL
to	NULL
the	NULL
PU.1	NULL
sites	NULL
in	NULL
SV40	NULL
,	NULL
c-fes	NULL
,	NULL
IgKk	NULL
3	NULL
'	NULL
,	NULL
and	NULL
J	NULL
chain	NULL
.	NULL

We	NULL
did	NULL
not	NULL
find	NULL
any	NULL
PU.1-binding	NULL
sites	NULL
that	NULL
failed	NULL
to	NULL
bind	NULL
IVT	NULL
Spi-B	NULL
.	NULL

210	NULL
J	NULL
chain	NULL
Ig	NULL
K3	NULL
'	NULL
DNA	NULL
complexes	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
Spi-B	NULL
in	NULL
B	NULL
cell	NULL
nuclear	NULL
extracts	NULL
can	NULL
also	NULL
bind	NULL
to	NULL
a	NULL
PU.1-binding	NULL
site	NULL
in	NULL
the	NULL
Igx	NULL
3	NULL
'	NULL
enhancer	NULL
,	NULL
a	NULL
series	NULL
of	NULL
binding	NULL
experiments	NULL
were	NULL
performed	NULL
on	NULL
extracts	NULL
obtained	NULL
from	NULL
clone	NULL
13	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

First	NULL
,	NULL
antibodies	NULL
specific	NULL
for	NULL
both	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
were	NULL
tested	NULL
for	NULL
cross	NULL
reactivity	NULL
on	NULL
purified	NULL
proteins	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

9	NULL
A	NULL
,	NULL
the	NULL
anti-PU.1	NULL
antibody	NULL
inhibited	NULL
PU.1	NULL
binding	NULL
to	NULL
a	NULL
c-fes	NULL
promoter	NULL
oligonucleotide	NULL
and	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
the	NULL
binding	NULL
of	NULL
IVT	NULL
Spi-B	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
anti-Spi-B	NULL
anti	NULL
Ets	NULL
Protein	NULL
Spi-B	NULL
Is	NULL
Expressed	NULL
Exclusively	NULL
in	NULL
B	NULL
Cells	NULL
and	NULL
T	NULL
Cells	NULL
Table	NULL
1	NULL
.	NULL

-	NULL
Compilation	NULL
of	NULL
the	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
Binding	NULL
Sites	NULL
B-globin	NULL
M-CSF	NULL
receptor	NULL
Foy	NULL
receptor	NULL
SV40	NULL
enhancer	NULL
C-fes	NULL
promoter	NULL
Ig	NULL
x-3	NULL
'	NULL
enhancer	NULL
Ig	NULL
J	NULL
chain	NULL
GATCACCTTCCTATCAGAAAAAAAGGGGAAGCGATTAT	NULL
TCGACCTAGCTAAAAGGGGAAGAAGAGGATCAGC	NULL
CTAGGCAATTTCCCTTCCTCTTTTCTAA	NULL
GATCTCGGGCTCGAGTCTGAAAGAGGAACTTGGTTA	NULL
GATCAAACCGCGGGAGGAGGAAGCGCGGAATCAGGA	NULL
GATCCCTTTGAGGAACTGAAAACAGAACCTAGATC	NULL
CTAGATTTTAAGAAAGCAGAAGCAGCAT	NULL
Galson	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
Perez	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
Ray	NULL
et	NULL
al	NULL
.	NULL

1992	NULL
Heydeman	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
Pongubala	NULL
et	NULL
al	NULL
.	NULL

1992	NULL
Shin	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
body	NULL
ablated	NULL
Spi-B	NULL
binding	NULL
but	NULL
did	NULL
not	NULL
affect	NULL
PU.1	NULL
binding	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
pre-immune	NULL
sera	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
binding	NULL
of	NULL
either	NULL
protein	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Having	NULL
demonstrated	NULL
that	NULL
these	NULL
antibodies	NULL
are	NULL
specific	NULL
for	NULL
either	NULL
PU.1	NULL
or	NULL
Spi-B	NULL
,	NULL
binding	NULL
assays	NULL
were	NULL
performed	NULL
on	NULL
human	NULL
B	NULL
cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

9	NULL
B	NULL
,	NULL
two	NULL
specific	NULL
complexes	NULL
were	NULL
detected	NULL
using	NULL
the	NULL
Igx	NULL
3	NULL
'	NULL
oligonucleotide	NULL
(	NULL
bands	NULL
2	NULL
and	NULL
3	NULL
in	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Both	NULL
of	NULL
these	NULL
complexes	NULL
were	NULL
competed	NULL
by	NULL
200	NULL
ng	NULL
of	NULL
cold	NULL
Igx	NULL
3	NULL
'	NULL
oligonucleotide	NULL
while	NULL
band	NULL
1	NULL
was	NULL
not	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Pre-immune	NULL
sera	NULL
did	NULL
not	NULL
affect	NULL
either	NULL
the	NULL
specific	NULL
or	NULL
non-specific	NULL
DNA-protein	NULL
complexes	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
antibody	NULL
specific	NULL
for	NULL
Spi-B	NULL
allowed	NULL
the	NULL
detection	NULL
of	NULL
a	NULL
DNA-protein	NULL
complex	NULL
with	NULL
a	NULL
rapid	NULL
mobility	NULL
and	NULL
the	NULL
antibody	NULL
specific	NULL
for	NULL
PU.1	NULL
allowed	NULL
the	NULL
detection	NULL
of	NULL
a	NULL
complex	NULL
with	NULL
a	NULL
slower	NULL
mobility	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
addition	NULL
of	NULL
anti-Spi-B	NULL
antibody	NULL
allowed	NULL
the	NULL
detection	NULL
of	NULL
the	NULL
rapidly	NULL
migrating	NULL
PU.1-DNA	NULL
complex	NULL
and	NULL
the	NULL
more	NULL
slowly	NULL
migrating	NULL
Spi-B-DNA	NULL
complex	NULL
was	NULL
revealed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
anti-PU.1	NULL
antibody	NULL
.	NULL

When	NULL
both	NULL
Spi-B	NULL
and	NULL
PU.1	NULL
antibodies	NULL
were	NULL
added	NULL
to	NULL
these	NULL
reactions	NULL
,	NULL
both	NULL
PU.1-	NULL
and	NULL
Spi-B-binding	NULL
were	NULL
eliminated	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

The	NULL
migration	NULL
of	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
was	NULL
confirmed	NULL
by	NULL
their	NULL
co-migration	NULL
with	NULL
IVT	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
both	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
in	NULL
clone	NULL
13	NULL
B	NULL
cell	NULL
nuclei	NULL
are	NULL
capable	NULL
of	NULL
binding	NULL
the	NULL
PU.1-binding	NULL
site	NULL
in	NULL
the	NULL
Igx	NULL
3	NULL
'	NULL
enhancer	NULL
in	NULL
an	NULL
in	NULL
vitro	NULL
assay	NULL
.	NULL

Spi-B	NULL
Functions	NULL
as	NULL
a	NULL
Transcriptional	NULL
Activator	NULL
of	NULL
a	NULL
B	NULL
Cell-specific	NULL
Gene	NULL
.	NULL

-	NULL
PU.1	NULL
and	NULL
Pip	NULL
(	NULL
PU.1	NULL
interaction	NULL
partner	NULL
)	NULL
form	NULL
a	NULL
B	NULL
cell-specific	NULL
heterodimeric	NULL
protein	NULL
complex	NULL
that	NULL
regulates	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
IgA	NULL
enhancer	NULL
Ey	NULL
;	NULL
,	NULL
(	NULL
21	NULL
)	NULL
.	NULL

PU.1	NULL
and	NULL
Pip	NULL
bind	NULL
to	NULL
a	NULL
composite	NULL
element	NULL
in	NULL
this	NULL
enhancer	NULL
that	NULL
is	NULL
essential	NULL
for	NULL
enhancer	NULL
activity	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
PU.1	NULL
and	NULL
Pip	NULL
function	NULL
as	NULL
mutually	NULL
dependent	NULL
transcriptional	NULL
activators	NULL
of	NULL
this	NULL
element	NULL
when	NULL
coexpressed	NULL
in	NULL
NIH-3T3	NULL
cells	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Having	NULL
shown	NULL
that	NULL
Spi-B	NULL
can	NULL
bind	NULL
to	NULL
multiple	NULL
PU.1-binding	NULL
sites	NULL
in	NULL
B	NULL
cell-specific	NULL
genes	NULL
,	NULL
we	NULL
wanted	NULL
to	NULL
learn	NULL
if	NULL
Spi-B	NULL
can	NULL
also	NULL
function	NULL
as	NULL
a	NULL
transactivator	NULL
of	NULL
the	NULL
lambda	NULL
Ey	NULL
,	NULL
,	NULL
element	NULL
.	NULL

The	NULL
AB	NULL
element	NULL
of	NULL
Ey	NULL
;	NULL
-	NULL
,	NULL
when	NULL
mul-timerized	NULL
and	NULL
placed	NULL
upstream	NULL
of	NULL
the	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
,	NULL
is	NULL
transactivated	NULL
by	NULL
PU.1	NULL
and	NULL
Pip	NULL
when	NULL
coexpressed	NULL
in	NULL
NIH-3T3	NULL
cells	NULL
(	NULL
21	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

10	NULL
,	NULL
neither	NULL
PU.1	NULL
nor	NULL
Pip	NULL
transactivated	NULL
the	NULL
AB	NULL
reporter	NULL
construct	NULL
(	NULL
B	NULL
,	NULL
TKCAT	NULL
)	NULL
when	NULL
expressed	NULL
alone	NULL
in	NULL
NIH-3T3	NULL
cells	NULL
.	NULL

How	NULL
211	NULL
Su	NULL
et	NULL
al	NULL
.	NULL

ever	NULL
,	NULL
if	NULL
both	NULL
PU.1	NULL
and	NULL
Pip	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
B	NULL
,	NULL
TKCAT	NULL
reporter	NULL
DNA	NULL
,	NULL
chloramphenical	NULL
acetyl	NULL
trans-ferase	NULL
(	NULL
CAT	NULL
)	NULL
activity	NULL
was	NULL
elevated	NULL
20-30-fold	NULL
.	NULL

If	NULL
Spi-B	NULL
and	NULL
Pip	NULL
were	NULL
cotransfected	NULL
with	NULL
B	NULL
,	NULL
TKCAT	NULL
,	NULL
CAT	NULL
expression	NULL
was	NULL
also	NULL
elevated	NULL
15-fold	NULL
.	NULL

Spi-B	NULL
expression	NULL
alone	NULL
failed	NULL
to	NULL
elevate	NULL
CAT	NULL
activity	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
Spi-B	NULL
acts	NULL
as	NULL
a	NULL
transcriptional	NULL
activator	NULL
in	NULL
conjunction	NULL
with	NULL
Pip	NULL
.	NULL

Eisenbeis	NULL
et	NULL
al	NULL
have	NULL
shown	NULL
that	NULL
PU.1	NULL
is	NULL
required	NULL
for	NULL
Pip	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
Ey	NULL
;	NULL
,	NULL
element	NULL
(	NULL
21	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
Spi-B	NULL
can	NULL
also	NULL
allow	NULL
Pip	NULL
binding	NULL
and	NULL
activate	NULL
transcription	NULL
.	NULL

Discussion	NULL
The	NULL
Ets	NULL
family	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
have	NULL
become	NULL
the	NULL
subject	NULL
of	NULL
extensive	NULL
investigation	NULL
as	NULL
key	NULL
regulators	NULL
of	NULL
immune	NULL
response	NULL
genes	NULL
and	NULL
cell	NULL
division	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
Ets	NULL
family	NULL
now	NULL
includes	NULL
~20	NULL
members	NULL
and	NULL
their	NULL
cellular	NULL
functions	NULL
and	NULL
target	NULL
genes	NULL
are	NULL
currently	NULL
being	NULL
analyzed	NULL
.	NULL

Spi-B	NULL
and	NULL
PU.1	NULL
share	NULL
a	NULL
67	NULL
%	NULL
amino	NULL
acid	NULL
Ets-domain	NULL
identity	NULL
and	NULL
43	NULL
%	NULL
overall	NULL
amino	NULL
acid	NULL
identity	NULL
(	NULL
12	NULL
)	NULL
.	NULL

It	NULL
is	NULL
essential	NULL
to	NULL
learn	NULL
if	NULL
Spi-B	NULL
and	NULL
PU.1	NULL
have	NULL
similar	NULL
patterns	NULL
of	NULL
expression	NULL
to	NULL
begin	NULL
to	NULL
understand	NULL
their	NULL
respective	NULL
functions	NULL
in	NULL
development	NULL
and	NULL
immune	NULL
cell	NULL
function	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
previous	NULL
reports	NULL
that	NULL
Spi-B	NULL
and	NULL
PU.1	NULL
are	NULL
coexpressed	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
hematopoietic	NULL
cells	NULL
(	NULL
12	NULL
,	NULL
25	NULL
)	NULL
,	NULL
our	NULL
data	NULL
clearly	NULL
showed	NULL
that	NULL
Spi-B	NULL
expression	NULL
is	NULL
restricted	NULL
to	NULL
T	NULL
and	NULL
B	NULL
lymphocytes	NULL
.	NULL

We	NULL
detected	NULL
no	NULL
human	NULL
Spi-B	NULL
RNA	NULL
or	NULL
protein	NULL
by	NULL
poly-A*	NULL
Northern	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
in	NULL
monocytic	NULL
or	NULL
erythroid	NULL
cells	NULL
.	NULL

We	NULL
attribute	NULL
the	NULL
divergent	NULL
results	NULL
to	NULL
the	NULL
different	NULL
probes	NULL
used	NULL
.	NULL

The	NULL
3'-UTR	NULL
of	NULL
Spi-B	NULL
was	NULL
used	NULL
in	NULL
all	NULL
of	NULL
our	NULL
Northern	NULL
blot	NULL
assays	NULL
as	NULL
opposed	NULL
to	NULL
the	NULL
full-length	NULL
cDNA	NULL
used	NULL
in	NULL
the	NULL
study	NULL
by	NULL
Ray	NULL
et	NULL
al	NULL
.	NULL

(	NULL
12	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
nucleotide	NULL
sequence	NULL
similarity	NULL
between	NULL
Spi-B	NULL
and	NULL
PU.1	NULL
human	NULL
cDNAs	NULL
in	NULL
the	NULL
DNA-binding	NULL
domain	NULL
is	NULL
75	NULL
%	NULL
(	NULL
12	NULL
)	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
the	NULL
myeloid	NULL
cell	NULL
expression	NULL
observed	NULL
in	NULL
the	NULL
previous	NULL
report	NULL
represents	NULL
cross	NULL
reaction	NULL
with	NULL
PU.1	NULL
.	NULL

Contrary	NULL
to	NULL
previous	NULL
reports	NULL
(	NULL
12	NULL
)	NULL
,	NULL
we	NULL
also	NULL
detected	NULL
Spi-B	NULL
expression	NULL
in	NULL
some	NULL
human	NULL
T	NULL
cell	NULL
lines	NULL
at	NULL
the	NULL
level	NULL
of	NULL
both	NULL
RNA	NULL
and	NULL
protein	NULL
.	NULL

The	NULL
polyclonal	NULL
antiserum	NULL
raised	NULL
against	NULL
a	NULL
human	NULL
Spi-B-GST	NULL
fusion	NULL
protein	NULL
was	NULL
able	NULL
to	NULL
Western	NULL
blot	NULL
,	NULL
immunoprecipitate	NULL
,	NULL
and	NULL
ablate	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
human	NULL
Spi-B	NULL
specifically	NULL
without	NULL
any	NULL
cross-reac-tivity	NULL
with	NULL
PU.1	NULL
.	NULL

In	NULL
Western	NULL
blot	NULL
analysis	NULL
,	NULL
Spi-B	NULL
protein	NULL
was	NULL
detected	NULL
in	NULL
all	NULL
B	NULL
cell	NULL
lines	NULL
and	NULL
one	NULL
T	NULL
cell	NULL
line	NULL
,	NULL
but	NULL
not	NULL
3|	NULL
%	NULL
a|3|	NULL
'	NULL
a|3|	NULL
'	NULL
a|3s	NULL
)	NULL
'	NULL
a	NULL
.	NULL

Protein	NULL
:	NULL
o	NULL
|	NULL
wm	NULL
|a	NULL
.	NULL

|	NULL
|a	NULL
|a	NULL
|a	NULL
|a	NULL
Antibody	NULL
:	NULL
_	NULL
PILL	NULL
|	NULL
-	NULL
|	NULL
-|	NULL
-|	NULL
-|	NULL
-	NULL
|+	NULL
]	NULL
+	NULL
(	NULL
t-Spi-B	NULL
=	NULL
|-	NULL
|-	NULL
|	NULL
-|	NULL
4	NULL
|	NULL
4	NULL
|-	NULL
|=	NULL
|	NULL
-	NULL
(	NULL
+	NULL
]	NULL
+	NULL
]	NULL
=|	NULL
~	NULL
|	NULL
=|	NULL
=	NULL
Ut	NULL
°	NULL
U	NULL
&	NULL
<	NULL
<	NULL
--	NULL
Spi-B	NULL
PU.1	NULL
|1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
Probe	NULL
:	NULL
c-fes	NULL
B	NULL
-|	NULL
.	NULL

3	NULL
|	NULL
a	NULL
.	NULL

Protein	NULL
:	NULL
Clone	NULL
13	NULL
Lysate	NULL
E	NULL
E	NULL
DNA	NULL
Competitor	NULL
:	NULL
|	NULL
-	NULL
|	NULL
+	NULL
|	NULL
-	NULL
|	NULL
-	NULL
|	NULL
-	NULL
|	NULL
-	NULL
|	NULL
-	NULL
|	NULL
Antibody	NULL
:	NULL
PHJ	NULL
-	NULL
|	NULL
-	NULL
)	NULL
+	NULL
]	NULL
=|	NULL
>	NULL
|	NULL
-|	NULL
-|-a-Spi-B|-	NULL
|-	NULL
|-	NULL
|+	NULL
|=	NULL
|	NULL
4+	NULL
|=	NULL
|-a-PUAJ-	NULL
|-	NULL
|-	NULL
|-	NULL
]	NULL
=-	NULL
|=	NULL
1	NULL
--	NULL
»	NULL
ti	NULL
@	NULL
oo	NULL
dit	NULL
2	NULL
-	NULL
»	NULL
e	NULL
®	NULL
.	NULL

«	NULL
sm	NULL
ﬁiu—	NULL
SpI-B	NULL
PU.1	NULL
|1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
)	NULL
Probe	NULL
:	NULL
Ig	NULL
K	NULL
3	NULL
Figure	NULL
9	NULL
.	NULL

-	NULL
Binding	NULL
of	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
from	NULL
clone	NULL
13	NULL
B	NULL
cell	NULL
nuclear	NULL
extracts	NULL
to	NULL
the	NULL
3	NULL
'	NULL
enhancer	NULL
of	NULL
Igx	NULL
.	NULL

(	NULL
4	NULL
)	NULL
A	NULL
radiolabeled	NULL
c-fes	NULL
promoter	NULL
oligonucleotide	NULL
was	NULL
used	NULL
in	NULL
EMSAs	NULL
with	NULL
IVT	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
pre-immune	NULL
serum	NULL
(	NULL
P1	NULL
)	NULL
or	NULL
antisera	NULL
specific	NULL
for	NULL
PU.1	NULL
or	NULL
Spi-B	NULL
were	NULL
added	NULL
to	NULL
DNA-binding	NULL
reactions	NULL
.	NULL

(	NULL
B	NULL
)	NULL
A	NULL
radiolabeled	NULL
oligonucleotide	NULL
from	NULL
the	NULL
Igx	NULL
3	NULL
'	NULL
enhancer	NULL
was	NULL
used	NULL
in	NULL
EMSAs	NULL
with	NULL
nuclear	NULL
extracts	NULL
obtained	NULL
from	NULL
clone	NULL
13	NULL
B	NULL
cells	NULL
.	NULL

Three	NULL
DNA/protein	NULL
complexes	NULL
were	NULL
detected	NULL
and	NULL
are	NULL
numbered	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
3	NULL
.	NULL

Where	NULL
indicated	NULL
pre-immune	NULL
(	NULL
P7	NULL
)	NULL
or	NULL
anti-PU.1	NULL
and	NULL
anti-Spi-B	NULL
antisera	NULL
were	NULL
added	NULL
to	NULL
DNA-binding	NULL
assays	NULL
.	NULL

200	NULL
ng	NULL
of	NULL
unlabeled	NULL
competitor	NULL
oligonucleotide	NULL
was	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
shown	NULL
in	NULL
lane	NULL
2	NULL
.	NULL

The	NULL
mobility	NULL
of	NULL
PU.1/DNA	NULL
and	NULL
Spi-B/DNA	NULL
complexes	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
left	NULL
.	NULL

40	NULL
fa	NULL
``	NULL
>	NULL
2	NULL
<	NULL
e	NULL
G	NULL
o	NULL
2	NULL
Fe	NULL
&	NULL
©	NULL
c	NULL
B4TKCAT	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
PU.1/PCDNA3	NULL
-	NULL
+	NULL
-	NULL
-	NULL
+	NULL
-Spi-	NULL
B/PCDNA3	NULL
_	NULL
-	NULL
-	NULL
+	NULL
-	NULL
-	NULL
+	NULL
PIP/CMV	NULL
-	NULL
-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
Figure	NULL
10	NULL
.	NULL

-	NULL
Functional	NULL
analysis	NULL
of	NULL
the	NULL
Spi-B	NULL
protein	NULL
.	NULL

PU.1	NULL
,	NULL
Spi-B	NULL
,	NULL
and	NULL
Pip	NULL
were	NULL
cloned	NULL
into	NULL
a	NULL
eukaryotic	NULL
expression	NULL
vector	NULL
containing	NULL
the	NULL
CMV	NULL
212	NULL
in	NULL
any	NULL
other	NULL
lineages	NULL
.	NULL

Spi-B	NULL
protein	NULL
levels	NULL
in	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
corresponded	NULL
to	NULL
RNA	NULL
levels	NULL
;	NULL
only	NULL
those	NULL
cells	NULL
with	NULL
high	NULL
Spi-B	NULL
mRNA	NULL
expression	NULL
had	NULL
detectable	NULL
Spi-B	NULL
protein	NULL
.	NULL

Spi-B	NULL
expression	NULL
in	NULL
both	NULL
B	NULL
cells	NULL
and	NULL
T	NULL
cells	NULL
appears	NULL
to	NULL
be	NULL
tightly	NULL
regulated	NULL
during	NULL
development	NULL
.	NULL

Pro-B	NULL
cells	NULL
had	NULL
the	NULL
lowest	NULL
levels	NULL
of	NULL
Spi-B	NULL
mRNA	NULL
and	NULL
expression	NULL
increased	NULL
in	NULL
pre-B	NULL
and	NULL
mature	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
notion	NULL
that	NULL
mature	NULL
B	NULL
cells	NULL
display	NULL
high	NULL
levels	NULL
of	NULL
Spi-B	NULL
expression	NULL
was	NULL
also	NULL
evident	NULL
in	NULL
tissue	NULL
studies	NULL
.	NULL

Spleen	NULL
,	NULL
lymph	NULL
nodes	NULL
,	NULL
and	NULL
purified	NULL
splenic	NULL
B	NULL
cells	NULL
exhibited	NULL
high	NULL
levels	NULL
of	NULL
Spi-B	NULL
expression	NULL
.	NULL

Spi-B	NULL
expression	NULL
was	NULL
highest	NULL
in	NULL
immature	NULL
CD4T	NULL
CD8~	NULL
T	NULL
cells	NULL
and	NULL
decreased	NULL
during	NULL
maturation	NULL
to	NULL
the	NULL
CD4*	NULL
CD8*	NULL
stage	NULL
of	NULL
development	NULL
.	NULL

These	NULL
findings	NULL
were	NULL
consistent	NULL
with	NULL
human	NULL
T	NULL
cells	NULL
and	NULL
murine	NULL
and	NULL
human	NULL
T	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
medullary	NULL
promoter	NULL
and	NULL
enhancer	NULL
.	NULL

The	NULL
reporter	NULL
is	NULL
the	NULL
B	NULL
,	NULL
TKCAT	NULL
construct	NULL
described	NULL
in	NULL
(	NULL
20	NULL
)	NULL
containing	NULL
four	NULL
AB	NULL
sites	NULL
upstream	NULL
of	NULL
the	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
.	NULL

The	NULL
indicated	NULL
DNAs	NULL
were	NULL
transiently	NULL
cotransfected	NULL
into	NULL
NIH-3T3	NULL
cells	NULL
and	NULL
extracts	NULL
were	NULL
analyzed	NULL
for	NULL
CAT	NULL
activity	NULL
48	NULL
h	NULL
later	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
B	NULL
,	NULL
TKCAT	NULL
alone	NULL
has	NULL
been	NULL
set	NULL
at	NULL
1.0	NULL
.	NULL

The	NULL
results	NULL
reported	NULL
are	NULL
an	NULL
average	NULL
of	NULL
four	NULL
independent	NULL
transfections	NULL
.	NULL

Ets	NULL
Protein	NULL
Spi-B	NULL
Is	NULL
Expressed	NULL
Exclusively	NULL
in	NULL
B	NULL
Cells	NULL
and	NULL
T	NULL
Cells	NULL
staining	NULL
observed	NULL
for	NULL
Spi-B	NULL
in	NULL
the	NULL
murine	NULL
thymus	NULL
would	NULL
appear	NULL
to	NULL
be	NULL
inconsistent	NULL
with	NULL
high	NULL
levels	NULL
of	NULL
Spi-B	NULL
RNA	NULL
in	NULL
CD4~	NULL
CD8~	NULL
T	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
not	NULL
clear	NULL
that	NULL
the	NULL
positive	NULL
selection	NULL
of	NULL
developing	NULL
thymocytes	NULL
is	NULL
restricted	NULL
to	NULL
the	NULL
thymic	NULL
cortex	NULL
(	NULL
26	NULL
)	NULL
.	NULL

It	NULL
remains	NULL
a	NULL
formal	NULL
possibility	NULL
that	NULL
CD47	NULL
CD8~	NULL
T	NULL
cells	NULL
reside	NULL
in	NULL
the	NULL
medulla	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
medullary	NULL
staining	NULL
observed	NULL
may	NULL
represent	NULL
expression	NULL
in	NULL
antigen	NULL
presenting	NULL
cells	NULL
(	NULL
B	NULL
cells	NULL
and	NULL
dendritic	NULL
cells	NULL
)	NULL
.	NULL

Other	NULL
than	NULL
the	NULL
thymus	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
lymph	NULL
nodes	NULL
,	NULL
Spi-B	NULL
was	NULL
virtually	NULL
undetectable	NULL
in	NULL
any	NULL
other	NULL
organ	NULL
of	NULL
either	NULL
embryonic	NULL
or	NULL
adult	NULL
mice	NULL
by	NULL
both	NULL
poly-A*	NULL
Northern	NULL
blot	NULL
analysis	NULL
and	NULL
in	NULL
situ	NULL
hybridization	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
Spi-B	NULL
is	NULL
clearly	NULL
distinct	NULL
from	NULL
that	NULL
of	NULL
PU.1	NULL
.	NULL

In	NULL
situ	NULL
hybridizations	NULL
of	NULL
fetal	NULL
and	NULL
adult	NULL
mouse	NULL
tissues	NULL
with	NULL
the	NULL
5	NULL
untranslated	NULL
region	NULL
of	NULL
PU.1	NULL
mRNA	NULL
previously	NULL
detected	NULL
PU.1	NULL
expression	NULL
in	NULL
bone	NULL
marrow	NULL
,	NULL
liver	NULL
,	NULL
and	NULL
spleen	NULL
of	NULL
adults	NULL
and	NULL
the	NULL
fetal	NULL
liver	NULL
of	NULL
day	NULL
18.5	NULL
embryos	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Further	NULL
analysis	NULL
showed	NULL
that	NULL
this	NULL
was	NULL
due	NULL
to	NULL
high	NULL
levels	NULL
of	NULL
PU.1	NULL
in	NULL
macrophages	NULL
,	NULL
neutrophils	NULL
,	NULL
mast	NULL
cells	NULL
,	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
immature	NULL
erythroid	NULL
cells	NULL
(	NULL
9	NULL
,	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Spi-B	NULL
expression	NULL
in	NULL
murine	NULL
tissues	NULL
is	NULL
limited	NULL
to	NULL
the	NULL
lymphoid	NULL
organs	NULL
(	NULL
thymus	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
lymph	NULL
nodes	NULL
)	NULL
and	NULL
is	NULL
not	NULL
detected	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
or	NULL
liver	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
Spi-B	NULL
expression	NULL
in	NULL
the	NULL
fetal	NULL
liver	NULL
suggests	NULL
that	NULL
Spi-B	NULL
is	NULL
not	NULL
present	NULL
in	NULL
immature	NULL
proerythroblasts	NULL
that	NULL
are	NULL
very	NULL
abundant	NULL
in	NULL
the	NULL
liver	NULL
during	NULL
days	NULL
12.5	NULL
to	NULL
16.5	NULL
of	NULL
gestation	NULL
.	NULL

Therefore	NULL
,	NULL
macrophages	NULL
,	NULL
neutrophils	NULL
,	NULL
and	NULL
red	NULL
blood	NULL
cells	NULL
which	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
PU.1	NULL
completely	NULL
lack	NULL
Spi-B	NULL
.	NULL

Furthermore	NULL
,	NULL
Spi-B	NULL
was	NULL
detected	NULL
in	NULL
T	NULL
cells	NULL
where	NULL
no	NULL
PU.1	NULL
expression	NULL
was	NULL
ob-served	NULL
.	NULL

Therefore	NULL
,	NULL
only	NULL
B	NULL
cells	NULL
and	NULL
CD4~	NULL
CD8~	NULL
T	NULL
cells	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
both	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
.	NULL

When	NULL
the	NULL
binding	NULL
affinities	NULL
of	NULL
IVT	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
were	NULL
compared	NULL
,	NULL
Spi-B	NULL
was	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
all	NULL
published	NULL
PU.1-binding	NULL
sites	NULL
albeit	NULL
with	NULL
less	NULL
affinity	NULL
in	NULL
some	NULL
cases	NULL
.	NULL

Since	NULL
both	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
are	NULL
present	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
it	NULL
is	NULL
interesting	NULL
that	NULL
both	NULL
were	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
3	NULL
'	NULL
enhancer	NULL
of	NULL
Ig	NULL
.	NULL

Although	NULL
,	NULL
Spi-B	NULL
bound	NULL
efficiently	NULL
to	NULL
the	NULL
PU.1	NULL
binding	NULL
sites	NULL
of	NULL
M-CSFR	NULL
,	NULL
FeyRI	NULL
,	NULL
and	NULL
the	NULL
scavenger	NULL
receptor	NULL
promoters	NULL
(	NULL
27	NULL
)	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
to	NULL
regulate	NULL
these	NULL
genes	NULL
as	NULL
it	NULL
is	NULL
not	NULL
present	NULL
in	NULL
monocytes	NULL
or	NULL
macrophages	NULL
.	NULL

It	NULL
is	NULL
intriguing	NULL
that	NULL
Spi-B	NULL
can	NULL
also	NULL
transactivate	NULL
a	NULL
reporter	NULL
construct	NULL
containing	NULL
the	NULL
PU.1	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
lambda	NULL
chain	NULL
Ey	NULL
;	NULL
,	NULL
enhancer	NULL
.	NULL

It	NULL
will	NULL
be	NULL
of	NULL
interest	NULL
to	NULL
learn	NULL
what	NULL
Spi-B	NULL
target	NULL
genes	NULL
exist	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
early	NULL
T	NULL
cells	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
play	NULL
nonredundant	NULL
roles	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
T	NULL
cells	NULL
:	NULL
gene	NULL
targeting	NULL
of	NULL
PU.1	NULL
leads	NULL
to	NULL
mice	NULL
lacking	NULL
B	NULL
cells	NULL
,	NULL
T	NULL
cells	NULL
,	NULL
monocytes	NULL
,	NULL
and	NULL
neutrophils	NULL
(	NULL
13	NULL
)	NULL
.	NULL

It	NULL
will	NULL
be	NULL
of	NULL
interest	NULL
to	NULL
learn	NULL
how	NULL
lymphocytic	NULL
development	NULL
and	NULL
function	NULL
are	NULL
affected	NULL
in	NULL
Spi-B-deficient	NULL
mice	NULL
.	NULL

We	NULL
thank	NULL
Harinder	NULL
Singh	NULL
and	NULL
Abe	NULL
Brass	NULL
for	NULL
the	NULL
B	NULL
,	NULL
TCAT	NULL
and	NULL
Pip/CMV	NULL
plasmids	NULL
and	NULL
Mike	NULL
Parmacek	NULL
for	NULL
helpful	NULL
discussions	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Cheryl	NULL
Small	NULL
for	NULL
her	NULL
careful	NULL
preparation	NULL
of	NULL
this	NULL
manuscript	NULL
.	NULL

This	NULL
research	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
HL52094-02	NULL
)	NULL
and	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
.	NULL

G.H	NULL
.	NULL

Su	NULL
is	NULL
supported	NULL
by	NULL
a	NULL
Genetics	NULL
training	NULL
grant	NULL
to	NULL
the	NULL
University	NULL
of	NULL
Chicago	NULL
.	NULL

Address	NULL
correspondence	NULL
to	NULL
M.	NULL
Celeste	NULL
Simon	NULL
,	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
The	NULL
University	NULL
of	NULL
Chicago	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
5841	NULL
S.	NULL
Maryland	NULL
Ave.	NULL
,	NULL
MC	NULL
1028	NULL
,	NULL
Chicago	NULL
,	NULL
IL	NULL
60637	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
24	NULL
January	NULL
1996	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
2	NULL
May	NULL
1996	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Robb	NULL
,	NULL
L.	NULL
,	NULL
I.	NULL
Lyons	NULL
,	NULL
R.	NULL
Li	NULL
,	NULL
L.	NULL
Hartley	NULL
,	NULL
F.	NULL
Kontgen	NULL
,	NULL
RP	NULL
.	NULL

Har-vey	NULL
,	NULL
D.	NULL
Metcalf	NULL
,	NULL
and	NULL
C.G	NULL
.	NULL

Begley	NULL
.	NULL

1995	NULL
.	NULL

Absence	NULL
of	NULL
yolk	NULL
sac	NULL
hematopoiesis	NULL
from	NULL
mice	NULL
with	NULL
a	NULL
targeted	NULL
disruption	NULL
of	NULL
the	NULL
sc	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

92:7075-7079	NULL
.	NULL

2	NULL
.	NULL

Shivdasani	NULL
,	NULL
R.A.	NULL
,	NULL
EL	NULL
.	NULL

Mayer	NULL
,	NULL
and	NULL
S.H	NULL
.	NULL

Orkin	NULL
.	NULL

1995	NULL
.	NULL

Absence	NULL
of	NULL
blood	NULL
formation	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
T-cell	NULL
leu-kaemia	NULL
oncoprotein	NULL
tal-1/SCL	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

373:432-434	NULL
.	NULL

3	NULL
.	NULL

Pevny	NULL
,	NULL
L.	NULL
,	NULL
M.	NULL
Simon	NULL
,	NULL
E.	NULL
Robertson	NULL
,	NULL
W.	NULL
Klein	NULL
,	NULL
S.-F.	NULL
Tsai	NULL
,	NULL
V.	NULL
D'Agati	NULL
,	NULL
S.	NULL
Orkin	NULL
,	NULL
and	NULL
F.	NULL
Costantini	NULL
.	NULL

1991	NULL
.	NULL

Erythroid	NULL
differentiation	NULL
in	NULL
chimeric	NULL
mice	NULL
blocked	NULL
by	NULL
a	NULL
targeted	NULL
mutation	NULL
in	NULL
the	NULL
gene	NULL
for	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

349:257-260	NULL
.	NULL

4	NULL
.	NULL

Simon	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
Pevny	NULL
,	NULL
M.	NULL
Wiles	NULL
,	NULL
G.	NULL
Keller	NULL
,	NULL
F.	NULL
Costantini	NULL
,	NULL
and	NULL
S.	NULL
Orkin	NULL
.	NULL

1992	NULL
.	NULL

Rescue	NULL
of	NULL
erythroid	NULL
development	NULL
in	NULL
gene-targeted	NULL
GATA~	NULL
embryonic	NULL
stem	NULL
cells	NULL
.	NULL

Nature	NULL
Genet	NULL
.	NULL

1:92-98	NULL
.	NULL

5	NULL
.	NULL

Georgopoulos	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
Bigby	NULL
,	NULL
J.H	NULL
.	NULL

Wang	NULL
,	NULL
A.	NULL
Molnar	NULL
,	NULL
P.	NULL
Wu	NULL
,	NULL
S.	NULL
Winandy	NULL
,	NULL
and	NULL
A.	NULL
Sharpe	NULL
.	NULL

1994	NULL
.	NULL

Early	NULL
arrest	NULL
in	NULL
lymphocyte	NULL
differentiation	NULL
in	NULL
Ikaros	NULL
mutant	NULL
mice	NULL
.	NULL

Cell	NULL
.	NULL

78:143-156	NULL
.	NULL

213	NULL
Su	NULL
et	NULL
al	NULL
.	NULL

6	NULL
.	NULL

Winandy	NULL
,	NULL
S.	NULL
,	NULL
P.	NULL
Wu	NULL
,	NULL
and	NULL
K.	NULL
Georgopoulos	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
dominant	NULL
mutation	NULL
in	NULL
the	NULL
Ikaros	NULL
gene	NULL
leads	NULL
to	NULL
rapid	NULL
development	NULL
of	NULL
leukemia	NULL
and	NULL
lymphoma	NULL
.	NULL

Cell	NULL
.	NULL

83:289-299	NULL
.	NULL

7	NULL
.	NULL

Corcoran	NULL
,	NULL
LM	NULL
.	NULL

,	NULL
M.	NULL
Karvelas	NULL
,	NULL
G.	NULL
Nossal	NULL
,	NULL
Z.-S.	NULL
Ye	NULL
,	NULL
and	NULL
T.	NULL
Jacks	NULL
.	NULL

1993	NULL
.	NULL

Oct-2	NULL
,	NULL
although	NULL
not	NULL
required	NULL
for	NULL
early	NULL
B-cell	NULL
de-velopment	NULL
,	NULL
is	NULL
critical	NULL
for	NULL
later	NULL
B-cell	NULL
maturation	NULL
and	NULL
for	NULL
postnatal	NULL
survival	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

7:570-582	NULL
.	NULL

8	NULL
.	NULL

Corcoran	NULL
,	NULL
LM	NULL
.	NULL

,	NULL
and	NULL
M.	NULL
Karvelas	NULL
.	NULL

1994	NULL
.	NULL

Oct-2	NULL
is	NULL
required	NULL
early	NULL
in	NULL
T	NULL
cell-independent	NULL
B	NULL
cell	NULL
activation	NULL
for	NULL
G1	NULL
progression	NULL
and	NULL
for	NULL
proliferatoin	NULL
.	NULL

Immunity	NULL
.	NULL

1:635-645	NULL
.	NULL

9	NULL
.	NULL

Hromas	NULL
,	NULL
R.	NULL
,	NULL
A.	NULL
Orazi	NULL
,	NULL
R.	NULL
Neiman	NULL
,	NULL
R.	NULL
Maki	NULL
,	NULL
C.	NULL
Van	NULL
Bev-eran	NULL
,	NULL
J.	NULL
Moore	NULL
,	NULL
and	NULL
M.	NULL
Klemsz	NULL
.	NULL

1993	NULL
.	NULL

Hematopoietic	NULL
lin-eage-	NULL
and	NULL
stage-restricted	NULL
expression	NULL
of	NULL
the	NULL
ETS	NULL
oncogene	NULL
family	NULL
member	NULL
PU.1	NULL
.	NULL

Blood	NULL
.	NULL

82:2998-3004	NULL
.	NULL

10	NULL
.	NULL

Klemsz	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
McKercher	NULL
,	NULL
A.	NULL
Celada	NULL
,	NULL
C.	NULL
Van	NULL
Beveren	NULL
,	NULL
and	NULL
R.	NULL
Maki	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
macrophage	NULL
and	NULL
B	NULL
cell-specific	NULL
transcription	NULL
factor	NULL
PU.1	NULL
is	NULL
related	NULL
to	NULL
the	NULL
ets	NULL
oncogene	NULL
.	NULL

Cell	NULL
.	NULL

61	NULL
:	NULL
113-124	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

Galson	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
Hensold	NULL
,	NULL
T.	NULL
Bishop	NULL
,	NULL
M.	NULL
Schalling	NULL
,	NULL
A	NULL
.	NULL

D'An-drea	NULL
,	NULL
C.	NULL
Jones	NULL
,	NULL
P.	NULL
Auron	NULL
,	NULL
and	NULL
D.	NULL
Houseman	NULL
.	NULL

1993	NULL
.	NULL

Mouse	NULL
b-globin	NULL
DNA-binding	NULL
protein	NULL
B1	NULL
is	NULL
identical	NULL
to	NULL
a	NULL
proto-oncogene	NULL
,	NULL
the	NULL
transcription	NULL
factor	NULL
Spi-1/Pu.1	NULL
,	NULL
and	NULL
is	NULL
restricted	NULL
in	NULL
expression	NULL
to	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:2929-2941	NULL
.	NULL

Ray	NULL
,	NULL
D.	NULL
,	NULL
R.	NULL
Bosselut	NULL
,	NULL
J.	NULL
Ghysdael	NULL
,	NULL
M.	NULL
Mattei	NULL
,	NULL
A.	NULL
Tavitian	NULL
,	NULL
and	NULL
F.	NULL
Moreau-Gachelin	NULL
.	NULL

1992	NULL
.	NULL

Characterization	NULL
of	NULL
Spi-B	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
related	NULL
to	NULL
the	NULL
putative	NULL
oncoprotein	NULL
Spi-1/	NULL
PU.1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:4297-4304	NULL
.	NULL

Scott	NULL
,	NULL
E.	NULL
,	NULL
M.	NULL
Simon	NULL
,	NULL
J.	NULL
Anastasi	NULL
,	NULL
and	NULL
H.	NULL
Singh	NULL
.	NULL

1994	NULL
.	NULL

Requirement	NULL
of	NULL
transcription	NULL
factor	NULL
PU.1	NULL
in	NULL
the	NULL
development	NULL
of	NULL
multiple	NULL
hematopoietic	NULL
lineages	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

265	NULL
:	NULL
1573-1577	NULL
.	NULL

Kuratani	NULL
,	NULL
S.	NULL
,	NULL
J.F	NULL
.	NULL

Martin	NULL
,	NULL
S.	NULL
Wawersik	NULL
,	NULL
B.	NULL
Lilly	NULL
,	NULL
G.	NULL
Eichele	NULL
,	NULL
and	NULL
EN	NULL
.	NULL

Olson	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
expression	NULL
pattern	NULL
of	NULL
the	NULL
chick	NULL
homeobox	NULL
gene	NULL
gMHox	NULL
suggests	NULL
a	NULL
role	NULL
in	NULL
patterning	NULL
of	NULL
the	NULL
limbs	NULL
and	NULL
face	NULL
and	NULL
in	NULL
compartmentalization	NULL
of	NULL
somites	NULL
.	NULL

Dev	NULL
.	NULL

Biol	NULL
.	NULL

161:357-369	NULL
.	NULL

Heydemann	NULL
,	NULL
A.	NULL
,	NULL
G.	NULL
Juang	NULL
,	NULL
K.	NULL
Hennessy	NULL
,	NULL
M.S	NULL
.	NULL

Parmacek	NULL
,	NULL
and	NULL
M.C	NULL
.	NULL

Simon	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
myeloid	NULL
cell-specific	NULL
c-fes	NULL
promoter	NULL
is	NULL
regulated	NULL
by	NULL
Sp1	NULL
,	NULL
PU.1	NULL
and	NULL
a	NULL
novel	NULL
transcription	NULL
factor	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:1676-1686	NULL
.	NULL

Pongubala	NULL
,	NULL
J.	NULL
,	NULL
S.	NULL
Nagulapalli	NULL
,	NULL
M.	NULL
Klemsz	NULL
,	NULL
S.	NULL
McKercher	NULL
,	NULL
R.	NULL
Maki	NULL
,	NULL
and	NULL
M.	NULL
Atchison	NULL
.	NULL

1992	NULL
.	NULL

PU.1	NULL
recruits	NULL
a	NULL
second	NULL
nuclear	NULL
factor	NULL
to	NULL
a	NULL
site	NULL
important	NULL
for	NULL
immunoglobulin	NULL
K3	NULL
'	NULL
enhancer	NULL
activity	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:368-378	NULL
.	NULL

Shin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
M.	NULL
Koshland	NULL
.	NULL

1993	NULL
.	NULL

Ets-related	NULL
protein	NULL
PU.1	NULL
regulates	NULL
expression	NULL
of	NULL
the	NULL
immunoglobulin	NULL
J-chain	NULL
gene	NULL
through	NULL
a	NULL
novel	NULL
Ets-binding	NULL
element	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

7:2006-2015	NULL
.	NULL

Zhang	NULL
,	NULL
D.	NULL
,	NULL
C.	NULL
Hetherington	NULL
,	NULL
H.	NULL
Chen	NULL
,	NULL
and	NULL
D.	NULL
Tenen	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
macrophase	NULL
transcription	NULL
factor	NULL
PU.1	NULL
directs	NULL
tissue-spe-cific	NULL
expression	NULL
of	NULL
the	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
receptor	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:373-381	NULL
.	NULL

Perez	NULL
,	NULL
C.	NULL
,	NULL
E.	NULL
Coeffier	NULL
,	NULL
F.	NULL
Moreau-Gachelin	NULL
,	NULL
J.	NULL
Wietzerbin	NULL
,	NULL
214	NULL
20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27.	NULL
and	NULL
P.	NULL
Benech	NULL
.	NULL

1994	NULL
.	NULL

Involvement	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
PU.1/Spi-1	NULL
in	NULL
myeloid	NULL
cell-restricted	NULL
expression	NULL
of	NULL
an	NULL
inter-feron-inducible	NULL
gene	NULL
encoding	NULL
the	NULL
human	NULL
high-affinity	NULL
Fog	NULL
receptor	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
,	NULL
Biol	NULL
.	NULL

14:5023-5031	NULL
.	NULL

Eisenbeis	NULL
,	NULL
C.	NULL
,	NULL
H.	NULL
Singh	NULL
,	NULL
and	NULL
U.	NULL
Storb	NULL
.	NULL

1993	NULL
.	NULL

PU.1	NULL
is	NULL
a	NULL
component	NULL
of	NULL
a	NULL
multiprotein	NULL
complex	NULL
which	NULL
binds	NULL
an	NULL
essential	NULL
site	NULL
in	NULL
the	NULL
murine	NULL
immunoglobulin	NULL
g2-4	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:6452-6461	NULL
.	NULL

Eisenbeis	NULL
,	NULL
C.F	NULL
.	NULL

,	NULL
H.	NULL
Singh	NULL
,	NULL
and	NULL
U.	NULL
Storb	NULL
.	NULL

1995	NULL
.	NULL

Pip	NULL
,	NULL
a	NULL
novel	NULL
IRF	NULL
family	NULL
member	NULL
,	NULL
is	NULL
a	NULL
lymphoid-specific	NULL
,	NULL
PU.1-dependent	NULL
transcriptional	NULL
activator	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

9:1377-1387	NULL
.	NULL

Shinkai	NULL
,	NULL
Y.	NULL
,	NULL
G.R	NULL
.	NULL

Rathbun	NULL
,	NULL
K.P	NULL
.	NULL

Lam	NULL
,	NULL
EM	NULL
.	NULL

Oltz	NULL
,	NULL
V.	NULL
Stew-art	NULL
,	NULL
M.	NULL
Mendelsohn	NULL
,	NULL
J.	NULL
Charron	NULL
,	NULL
M.	NULL
Datta	NULL
,	NULL
F.	NULL
Yang	NULL
,	NULL
A.M	NULL
.	NULL

Stall	NULL
et	NULL
al	NULL
.	NULL

1992	NULL
.	NULL

RAG-2-deficient	NULL
mice	NULL
lack	NULL
mature	NULL
lympho-cytes	NULL
owing	NULL
to	NULL
inability	NULL
to	NULL
initiate	NULL
V	NULL
(	NULL
D	NULL
)	NULL
]	NULL
rearrangement	NULL
.	NULL

Cell	NULL
.	NULL

68:855-867	NULL
.	NULL

Baier	NULL
,	NULL
T.G	NULL
.	NULL

,	NULL
EW	NULL
.	NULL

Jenne	NULL
,	NULL
W.	NULL
Blum	NULL
,	NULL
D.	NULL
Schonberg	NULL
,	NULL
and	NULL
K.K.P	NULL
.	NULL

Hartmann	NULL
.	NULL

1992	NULL
.	NULL

Influence	NULL
of	NULL
antibodies	NULL
against	NULL
IGF-1	NULL
,	NULL
insulin	NULL
or	NULL
their	NULL
receptors	NULL
on	NULL
proliferation	NULL
of	NULL
human	NULL
acute	NULL
lym-phoblastic	NULL
leukemia	NULL
cell	NULL
lines	NULL
.	NULL

Leukemia	NULL
Res	NULL
.	NULL

16:807-814	NULL
.	NULL

Crepieux	NULL
,	NULL
P.	NULL
,	NULL
J.	NULL
Coll	NULL
,	NULL
and	NULL
D.	NULL
Stehelin	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
Ets	NULL
family	NULL
of	NULL
proteins	NULL
:	NULL
weak	NULL
modulators	NULL
of	NULL
gene	NULL
expression	NULL
in	NULL
quest	NULL
for	NULL
transcriptional	NULL
partners	NULL
.	NULL

Oncogene	NULL
.	NULL

5:615-638	NULL
.	NULL

Ray-Gallet	NULL
,	NULL
D.	NULL
,	NULL
C.	NULL
Mao	NULL
,	NULL
A.	NULL
Tavitian	NULL
,	NULL
and	NULL
F.	NULL
Moreau-Gachelin	NULL
.	NULL

1995	NULL
.	NULL

DNA	NULL
binding	NULL
specificities	NULL
of	NULL
Spi-1/PU.1	NULL
and	NULL
Spi-B	NULL
transcription	NULL
factors	NULL
and	NULL
identification	NULL
of	NULL
a	NULL
Spi-1/Spi-B	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
c-fes/c-fps	NULL
promoter	NULL
.	NULL

Oncogene	NULL
.	NULL

11:303-313	NULL
.	NULL

Hugo	NULL
,	NULL
P.	NULL
,	NULL
J.	NULL
W.	NULL
Kappler	NULL
,	NULL
and	NULL
P.C	NULL
.	NULL

Marrack	NULL
.	NULL

1993	NULL
.	NULL

Positive	NULL
selection	NULL
of	NULL
TcRab	NULL
thymocytes	NULL
:	NULL
is	NULL
cortical	NULL
thymic	NULL
epithelium	NULL
an	NULL
obligatory	NULL
participant	NULL
in	NULL
the	NULL
presentation	NULL
of	NULL
major	NULL
histo-compatibility	NULL
complex	NULL
protein	NULL
?	NULL

Immunol	NULL
.	NULL

Rep.	NULL
135:133-155	NULL
.	NULL

Moulton	NULL
,	NULL
K.	NULL
,	NULL
K.	NULL
Semple	NULL
,	NULL
H.	NULL
Wu	NULL
,	NULL
C.	NULL
Glass	NULL
.	NULL

1994	NULL
.	NULL

Cell-specific	NULL
expression	NULL
of	NULL
the	NULL
macrophase	NULL
scavenger	NULL
receptor	NULL
gene	NULL
is	NULL
dependent	NULL
on	NULL
PU.1	NULL
and	NULL
a	NULL
composite	NULL
AP-1/ets	NULL
motif	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:4408-4418	NULL
.	NULL

Ets	NULL
Protein	NULL
Spi-B	NULL
Is	NULL
Expressed	NULL
Exclusively	NULL
in	NULL
B	NULL
Cells	NULL
and	NULL
T	NULL
Cells	NULL

